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1 INTRODUCTION AND RESEARCH AIMS 
 
1.1  INTRODUCTION  
 
1.1.1  The general introduction to the Campylobacter genus and a brief overview of the 
research challenges  
 
Bacteria of Campylobacter genus are small, gram negative, spirally shaped organisms with a 
single polar flagellum at one or both sides, but some are also non-motile. Campylobacters 
are thermophilic microorganisms with optimal growth at 37 to 42 ºC. Due to absence of cold 
shock response they are incapable of growth below 30 ºC. Almost all species have active 
oxidase. Because they do not metabolize majority of carbohydrates, they tend to obtain 
energy from utilizing amino acids or Krebs cycle intermediates. C. jejuni hydrolyses 
hippurat and indoxyl acetate and reduces nitrate, which is exploited in its biochemical 
differentiation from other Campylobacter species (Vandamme, 2000). One of the 
specialities of these bacteria is the requirement of microaerophilic environment for optimal 
growth. They are also known to change the physiological and morphological state to so 
called viable but non-culturable state in unfavourable environment and when exposed to 
stress. This is also one of the factors which make them difficult to isolate (Kassem et al., 
2013). 
 
The history of Campylobacter discovery is thought to go back to the far year of 1886, when 
Theodor Escherich, the famous German-Austrian paediatrician and also a professor at 
university in Graz, has first described it as non-culturable bacteria of spiral shape (Shulman, 
2007; Vandamme, 2010). Later on the bacteria were frequently found in sheep uterus, 
aborted bovine fetuses, cattle and pig faeces and were named Vibrio jejuni and V. coli (Silva 
et al., 2011). It was not recognized as Campylobacter genus (campylos meaning curved in 
Greek) until 1963, when this group of bacteria was distinguished from Vibrio based on the 
smaller genome size, non-fermentative metabolism and microaerophilic respiration (Silva et 
al., 2011). 
 
Campylobacters started to draw attention in the early seventies, when Butzler and co-
workers started a systematic search for vibrio related microorganisms in stools of children 
and adults (Butzler et al., 1973). With this pioneer study and invention of the first 
Campylobacter selective agar, they have laid the foundation of Campylobacter research. 
Soon after, new studies with successfully isolated Campylobacter spp. from children with 
characterized clinical background have followed (Bokkenheuser et al., 1979). In those times 
C. fetus specific bacteriophages were also successfully introduced for the first time as the 
potential antimicrobials. At the same time this was the ground-breaking era of recognizing 
Campylobacter genus as a causative agent of human disease, which has increased an interest 
in this pathogen and accelerated the research in the field of campylobacteriosis. However, it 
was not known at that time, that bacteria can be transmitted with food, so the mystery of its 
origin was yet to be unravelled.  
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Today we know that campylobacteriosis is a zoonotic disease that can be transmitted to 
humans directly from animals, or via foodstuffs. While it usually does not cause any disease 
symptoms in animals, the human infection reflects in elevated body temperature, diarrhoea 
and abdominal cramps. In some cases also post-infectious disorders, such as Guillain-Barré 
syndrome occur (EFSA, 2014a). 
 
Campylobacter spp. is acknowledged as the most common bacterial foodborne cause of 
gastroenteritis in EU, as well as in other parts of the developed world (EFSA, 2014a). The 
trend of its increasing prevalence is recorded ever since the European Food Safety Authority 
(EFSA) was established and started to monitor the trends and sources of zoonoses, zoonotic 
agents and food-borne outbreaks in the EU. Moreover, the officially reported numbers are 
thought to be significantly underestimated, due to different levels of underdiagnosis and 
underreporting among different countries (Haagsma et al., 2012). It is therefore no surprise, 
that tremendous efforts are invested, economic- as well as research-wise, to elucidate the 
epidemiological characteristics of campylobacters. The sound scientific results on this 
subject could namely contribute to efficient policy making in the field, resulting in decrease 
of the disease burden.  
With the effective use of molecular tools in the last decade, it has become clear that meat, 
especially poultry, is the major source of Campylobacter infections, although other, 
especially environmental sources are thought to be underestimated (Sheppard et al., 2010). 
A great contribution to this endeavour was the establishment of multi locus sequence typing 
scheme for Campylobacter jejuni in 2001 (Dingle et al., 2001), as well as other source-
tracing genotyping methods (Stabler et al., 2013). This has triggered a new wave of studies 
in Campylobacter molecular epidemiology with focus on tracing the pathogen along the 
food production chain and exploiting the available techniques for investigation of foodborne 
outbreaks and following the spreading of highly pathogenic clones (Muhammad et al., 2011; 
Sahin et al., 2012; Kwan et al., 2014). These techniques are lately advantageously used also 
in studying the antibiotic resistance expansion (Kittl et al., 2013, Wimalarathna et al., 2013; 
Kovač et al., 2014).  
The resistance against ciprofloxacin, one of the first drugs of choice for treatment of 
gastrointestinal diseases, including campylobacteriosis, is substantially increasing among 
campylobacters, with the increasing trend being more pronounced in southern European 
countries, including Slovenia (Smole Možina et al., 2011; EFSA, 2014b). Due to the acute 
nature of infectious diseases, the antimicrobial drug discovery is not a priority in 
pharmaceutical industry. In order to solve this problem, therefore a lot of academic research 
is focused on finding new antimicrobial compounds. In this aspect plant kingdom represents 
a valuable source of bioactive constituents that is not yet fully exploited. In the last years 
several new anti-Campylobacter natural products have been identified, some possessing a 
direct antimicrobial activity, while others having a resistance-modulatory potential, meaning 
they can potentiate the activity of existing antibiotics when administered together (Klančnik 
et al., 2012a; Klančnik et al., 2012b; Kurinčič et al., 2012; Kovač et al., 2014b). The most 
promising strategy of resistance modulation approach seems to be inhibition of bacterial 
efflux and will be presented more in detail later on. 
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1.1.2  Campylobacter prevalence and its underreporting issues  
 
In 2002 the EU established the independent agency called The European Food Safety 
Authority (EFSA) to monitor and collect information on zoonoses. Today all EU member 
states are obliged to collect and report relevant data on zoonoses, zoonotic agents and 
antimicrobial resistance and food-borne outbreaks according to the Zoonoses Directive 
2003/99/EC. One of the food-borne pathogens included in the monitoring scheme is also 
Campylobacter spp., which is followed in animals, foodstuffs and humans. Among 
campylobacters, C. jejuni is the species most commonly associated with human disease 
(EFSA, 2014a). 
 
The notification rate of campylobacteriosis in 2012 was 55.49/100,000, which was for 4.3% 
less than the year before that. The prevalence of campylobacteriosis in Slovenia was 
somewhat lower with 47.83 cases per 100,000. This was the first decrease in reported cases 
on the EU level in the last five reporting years. In the years 2008-2012 the clear seasonal 
trend with peak of the reported cases in summer months was observed, as well as the clear 
increase in the reported cases of human campylobacteriosis. In contrast to high 
hospitalization rate (47.7%), low mortality (0.03%) is reported, probably due to selflimiting 
nature of the disease and often mild symptoms. Campylobacter was also on the fourth place 
of known causes of outbreaks with weak and strong evidence altogether. Outbreaks, which 
are less common than sporadic cases, are usually caused by ingestion of contaminated milk 
or water (EFSA, 2014a). 
 
To protect consumers from health risks associated with food-borne pathogens, EFSA has 
implemented an integrated ''farm to fork'' approach to study the food safety. Part of this 
approach is risk assessment based on the collected data, as well as risk management, which 
is based on the sound output of the scientific analyses. The risk management is performed in 
cooperation of EU member states with European commission, European Parliament, EFSA 
and the European Centre for Disease Prevention and Control, in order to ensure efficient risk 
communication and protect the consumers (EFSA, 2014a). 
 
As the prevalence of foodborne diseases is thought to be significantly underestimated, there 
is a need to evaluate the effectiveness of the reporting process in order to assess the real 
burden of disease. The prevalence is underestimated due to underreporting and 
underdiagnosis associated with passive surveillance, incorrect diagnosis and inefficient 
communication with authorities, as well as with the unregistered cases with mild symptoms 
that do not seek medical help. Prevalence is normative, characterizing the rate of cases in a 
population at a specific time and is easy to visualize and compare. It is measured from finite 
samples and the reported cases behave according to a binomial process; therefore 
uncertainty in prevalence can be described by beta distributions. Prevalence can be 
considered as the probability for a binomial process and the uncertainty about prevalence is 
the probability density of the binomial parameter which has a beta distribution. Existing 
belief about the prevalence can therefore be systematically updated given the data from 
successive finite samples. Bayes’ theorem can be used to express how to rationally change a 
subjective belief by taking evidence into account. Model parameters affecting the prevalence 
reporting by general practitioners (GPs) can be defined in order to construct a probabilistic 
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graphical model. Since different parameters affecting the process of reporting are involved 
in cases of hospitalization, these have to be acknowledged with a separate branch of the 
model. Because of the differences in symptoms and severity of the disease caused by 
different pathogens, as well as the differences in medical and reporting practice among EU 
countries, some of the parameters are dependent of the country and others of the pathogen 
(Haagsma et al., 2012).  
 
Most of the studies approach to reconstruction of the surveillance pyramid for foodborne 
diseases by evaluating few vital fractions, which estimate the underdiagnosis and 
underreporting rate of the diseases. These include the probability for a gastroenteritis patient 
to visit a GP, for a GP to submit a stool, for a positive result and for a positive result to be 
reported. The odds for diarrhoea case to seek medical help and for a GP to submit the 
patient’s stool sample for microbiological analysis are the most important components 
contributing to the overall notification fraction according to the data from previous studies 
(Michel et al., 2000; Scallan et al., 2006; Hall et al., 2008; Scallan et al, 2011; Haagsma et 
al., 2012). Moreover, the medical help seeking behaviour, as well as GP decision making is 
influenced by the severity of symptoms, thus the cases experiencing bloody and non-bloody 
diarrhea were often analysed separately (Scallan et al., 2006; Scallan et al., 2011; Haagsma 
et al., 2012). Although some studies report similar proportions of diarrhoea cases seeking 
medical health despite the differences in structure and access to health care systems in 
Australia, Canada, Ireland and United States (Scallan et al., 2005), other reveal significant 
differences in medical help seeking behaviour among countries within EU (Haagsma et al, 
2012).  
 
In our study, parameters were modelled using linear regression based on existing data for 
seven foodborne pathogens in seven EU countries and only common statistical data 
available for EU countries was used to model the parameter uncertainty distributions. Monte 
Carlo simulations of modelled parameters were used to estimate beliefs about prevalence of 
foodborne pathogens in additional EU countries. Furthermore, the sensitivity of parameters 
comprizing the prevalence model was examined.  
 
1.1.3  Tracing Campylobacter along the food chain and detecting the source of 
infection 
 
Modern molecular tracing techniques, like pulsed field gel electrophoresis (PFGE) and multi 
locus sequence typing (MLST) have been widely used to trace the Campylobacter along the 
food chain and to identify the sources of sporadic and outbreak cases (Roux et al., 2013; 
Kovač et al., 2014a; Kittl et al., 2014; Kwan et al., 2014). Although PFGE is known as a 
golden standard among genotyping methods, the MLST begins to take over the lead. There 
are several reasons for its successful establishment in molecular epidemiological studies of 
Campylobacter, although it is not competitive concerning the cost of analysis. Firstly, the 
method is portable, completely reproducible and the results are easily comparable among 
different laboratories, secondly a user-friendly publicly available database called PubMLST 
was build by the University of Oxford molecular epidemiology research group, which 
currently has over 29000 entries (Cody et al., 2010a). The MLST community is constantly 
increasing and public health authorities like European Centre for Disease Control and 
Prevention (ECDC) are starting to implement it in their epidemiological studies (Kwan et 
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al., 2014). Since the price of sequencing is rapidly decreasing due to the implementation of 
the highly efficient next generation sequencing, MLST is expected to become more 
affordable and widely accepted as the method of first choice also in the routine laboratories. 
Even more, the advanced laboratories are already beginning to implement the extended 
MLST schemes like ribosomal multi locus sequence typing (rMLST) and whole genome 
MLST (Jolley et al., 2012; Cody et al., 2013). The rMLST examines the variation of 53 
genes, instead of only seven housekeeping genes and it includes ribosomal genes. 
Ribosomal MLST is integrating typing and genealogy, while whole genome MLST 
(wgMLST) provides definitive characterization of C. jejuni and C. coli and is proposed to be 
used in a routine as a practical and rapid exploitation of whole-genome sequencing (Jolley et 
al., 2012; Cody et al., 2013). 
 
 
1.1.4  Campylobacter antibiotic resistance prevalence and spreading  
 
The increasing incidence of antibiotic resistant bacteria reflects in the impaired efficacy of 
clinical treatments, prolonged illness and greater mortality due to infectious diseases. The 
decline in new antibiotic discovery in the last decades, with only two antibiotics from new 
classes being brought on the EU market since the 1970s, poses serious economic and public 
health threat.  Not only 25,000 patients dying due to incurable infections with multidrug-
resistant (MDR) bacteria, but also the European healthcare budget being burdened for at 
least 1.5 billion additional euros each year because of the prolonged treatments of MDR 
infections is concerning (ECDC, 2009). C. jejuni, being the most prevalent bacterial cause of 
gastroenteritis and with high rates of ciprofloxacin resistance, is an important part of this 
issue (EFSA, 2014a; EFSA 2014b). Drug resistant Campylobacter is on the CDC’s list of 
serious threats, causing 120 deaths per year in the US alone, and its threat is expected to 
worsen without ongoing public health monitoring and preventing activities (CDC, 2013). 
According to EFSA (2014b), high resistance of campylobacters to ciprofloxacin, nalidixic 
acid and tetracycline exists in EU countries. On the other hand, they are susceptible to the 
first drug of choice for campylobacteriosis treatment, erythromycin, as well as gentamicin. 
Especially resistance against fluoroquinolones, which is commonly observed in isolates 
from broilers, chicken meat, pigs and cattle, is of great concern. It is ranging from 32 to 83% 
among different EU Member states (EFSA, 2014b). Fluoroquinolones are usually the first 
drug of choice for treatment of gastrointestinal infections with unknown causative agent; 
this is why the increasing resistance can seriously impair effective clinical treatment. In 
Slovenia, the ciprofloxacin resistance of human Campylobacter spp. isolates is extremely 
high, with 68% resistance rate (N=981), which is significantly higher than the EU average 
(47%, N=36,172). When considering C. jejuni alone, the rate is by more than half lower 
(31%; N=1,044) and is below the EU average (54%, N=11,551). Alarming is also the high 
rate of multidrug resistance (24%, N=695), while co-resistance to ciprofloxacin and 
erythromycin is kept at a low level (0.7%). The ciprofloxacin resistance of human C. coli is 
higher (75%, N=55) than of C. jejuni, but C. coli represents only a minority of total human 
Campylobacter infections (EFSA, 2014a; EFSA, 2014b).  
 
The rapidly increasing resistance of campylobacters against clinically used antibiotics raises 
a lot of interest in how the antibiotic resistance is acquired and spread among bacterial 
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population. It is known that bacteria of Campylobacter genus are naturally competent and 
can take up the genes from the environment via horizontal gene transfer (Vegge et al., 2012; 
Gaasbeek et al., 2010). The horizontal gene transfers also present one of the ways for the 
antibiotic resistance genes to spread. For example tetO, which encodes ribosomal protection 
protein and provides resistance against tetracycline is one of the typical examples of 
resistance genes in Campylobacter spp. (Pérez-Boto et al., 2014). Based on GT content, 
sequence homology, codon usage and hybridization it is suggested that Campylobacter tetO 
gene was acquired by horizontal transfer from Streptomyces, Streptococcus or Enterococcus 
spp. (Luangtongkum et al., 2009). The gene is in most strains plasmid-encoded, although it 
can also be found on the chromosome of some species (Luangtongkum et al., 2009). It is 
therefore possible that the Campylobacter can uptake the tetO resistance gene from other 
bacteria present in the gut of the colonized animals via horizontal gene transfer or 
recombination events.  
 
On the other hand, there are antibiotics to which resistance is provided by point mutations in 
the genes which usually code for the target of antibiotic action. Examples are erythromycin 
with mutation A2075G in 23S rRNA and ciprofloxacin with mutation Thr86Ile in quinolone 
resistance determining region (QRDR) of gyrase gene gyrA (Iovine, 2013; Kurinčič et al., 
2007). Quite some time ago it was found that acquirement of point mutation in gyrA QRDR 
not only provides C. jejuni with resistance to quinolones, but also enhanced their survival 
fitness when colonizing chickens in competition with ciprofloxacin susceptible strains. 
Surprisingly, this feature is preserved even in the absence of antibiotic selective pressure 
(Hyytiäinen et al., 2013; Luo et al., 2005). The opposite was observed in case of 
erythromycin resistant strains, which were outcompeted in transmission and host 
colonization by susceptible C. jejuni strains (Luangtongkum et al., 2012). The latter 
somewhat explains the low reported prevalence of erythromycin resistance among 
campylobacters, however it is important to note that high resistance to fluoroquinolones 
exists also due to the extensive use of this class of antibiotics in veterinary medicine, while 
use of macrolides in veterinary is more rational since the EU banned its use for growth 
promotion of farm animals (EMA, 2011a; EMA, 2011b). The long-term exposure to sub-
inhibitory concentrations of macrolides namely results in higher frequency of resistant 
isolates compared to treatment with therapeutic doses (EMA, 2011b). The resistance of 
these types of antibiotics can expand by acquisition of individual mutations in new strains or 
by clonal spreading of resistant strains with increased survival fitness.  
 
 
1.1.5  Overcoming the antibiotic resistance in Campylobacter jejuni 
  
Search for alternative antimicrobials derived from plants seems to be a viable solution for 
mitigation of existing bacterial antibiotic resistance (Savoia et al., 2012). In addition to 
searching for new antimicrobially active plant formulations, the antibiotic resistance 
combating strategies are focused also on resistance modulators. These are not necessarily 
antimicrobially active, but can decrease the resistance of pathogens when administered 
together with other antimicrobials. The microbial sensitization using resistance modulators 
is mostly due to efflux inhibition, increased membrane permeability, increased porin 
production or change in porin profile (Bolla et al., 2011; Tegos et al., 2011). Active efflux is 
Kovač J. Antimicrobial and modulatory activity of selected phytochemicals …  antibiotic resistance in Campylobacter jejuni.  
    Doctoral dissertation. Ljubljana, University of Ljubljana, Biotechnical Faculty, 2015                                                                7 
 
 
 
 
one of the most important contributors to the bacterial multidrug resistance, since it helps 
bacteria to extrude antimicrobials of broad specificity out of the cells. The most important 
efflux pump in C. jejuni is CmeABC, along with CmeDEF and CmeG (Lin et al., 2002; 
Akiba et al., 2006; Jeon et al., 2011).  These efflux pumps alone or in combination with 
specific point mutations and antibiotic resistance genes provide increased resistance of 
bacteria against several different classes of antibiotics.  
 
Plant extracts rich in phenolic compounds, and essential oils have long been shown to 
possess antimicrobial activity and were frequently studied and reviewed (Cowan, 1999; 
Burt, 2004; Negi, 2012; Klančnik et al., 2012a). In order to restore the activity of already 
existing antibiotics on the market, a lot of research is therefore focused on finding new 
compounds from plant sources with ability to inhibit bacterial efflux (Klančnik et al., 2012a; 
Klančnik et al., 2012b; Kurinčič et al., 2012). To the date, no efflux pump inhibitor has been 
licensed for clinical use, although some of the drugs like calcium ion influx inhibitor 
verapamil, which is licensed for arrhythmia treatment, possess also efflux inhibitory activity 
(Mahamoud et al., 2007). Still, many new compounds, especially from the natural sources, 
have recently been identified as potential efflux pump inhibitors in the in vitro assays (Stavri 
et al., 2007; Gröblacher et al., 2012a; Gröblacher et al., 2012b; Shiu et al., 2013). They are 
especially interesting as they have a potential to be used as preservatives in food products. 
One of the plants interesting from this aspect is Alpinia katsumadai Hayata (syn. A. 
katsumadae Hayata; Zingiberaceae) (Gröblacher et al., 2012a). It is widely used in 
traditional Chinese medicine as an anti-emetic remedy and to increase the appetite, but also 
in animal feed, to facilitate rapid growth of domestic animals (Klančnik et al., 2012a). 
 
In our studies we have focused on investigating anti-Campylobacter, resistance modulatory 
and efflux inhibitory potential of an A. katsumadai seed extract, essential oil and waste 
material that remains after essential oil production (Klančnik et al., 2012; Kovač et al., 
2014b). Such residual materials are often disposed of and may present an environmental 
problem. Their high phenolic content and the potential to provide an economically feasible 
source of natural antioxidants and antimicrobials is still unused (Moure, 2000).   
 
One of the natural compounds, which were proven to have antimicrobial activity against 
various microorganisms, is a terpen compound α-pinene, naturally found in several essential 
oils, including that of A. katsumadai (da Silva et al., 2012; Wang et al., 2012; Thu et al., 
2013; Sieniawska et al., 2013). Alpha pinene naturally exists in two enantiomers, (+)-α-
pinene and (-)-α-pinene. The latter was investigated in one of our studies for its 
antimicrobial, resistance-modulatory and efflux-inhibitory potential on a set of antibiotic 
resistant and susceptible Campylobacter jejuni isolates from different sources.  
 
1.1.6  Campylobacter jejuni adaptational response to treatment with antimicrobial and 
resistance modulatory compounds 
 
In the last years several expressional studies of Campylobacter response to treatment with 
different antimicrobials have been carried out. Two of those have analyzed the bacterial 
adaptation to antibiotics erythromycin (Xia et al., 2013) and ciprofloxacin (Han et al., 2008) 
and one to natural antimicrobial product (Dufour et al., 2013). It was found that C. jejuni 
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adapts to erythromycin treatment by up-regulation of motility genes and down-regulation of 
energy metabolism genes, which helps the bacteria to survive this chemical stress (Xia et al., 
2013). Similar analysis of C. jejuni response to treatment with ciprofloxacin revealed that 
the gene mfd plays an important role in bacterial adaptation to this antibiotic. It was 
demonstrated, that the mutation of these gene results in 100-fold reduction in the rate of 
spontaneous mutation to ciprofloxacin resistance, while overexpression elevates the 
ciprofloxacin resistance conferring mutation rate (Han et al., 2008). The treatment of C. 
jejuni with phytochemical benzyl isothiocyanate resulted in up-regulation of heat shock 
response genes and impact on energy metabolism. The consequence of treatment was the 
impaired oxygen consumption and increased ATP content, as well as increased intracellular 
protein aggregation (Dufour et al., 2013). 
We have investigated transcriptomic response of C. jejuni to treatment with resistance 
modulatory efflux inhibitor (-)-α-pinene, in order to elucidate the mode of its action. 
 
 
1.2  THE RESEARCH AIMS 
 
 
• To evaluate the underreporting of Campylobacter spp. prevalence in Slovenia; 
• To investigate the correlation between antibiotic resistance and certain 
Campylobacter jejuni genotypes; 
• To investigate the  anti-Campylobacter, resistance modulatory and efflux inhibitory 
activity of Alpinia katsumadai seed extract and essential oil, as well as the extract 
from residual material left after the distillation of the essential oil; 
• To evaluate the potential of (-)α-alpha-pinene to inhibit the efflux systems CmeABC 
and Cj1687 of Campylobacter jejuni; 
• To evaluate the bacterial response to treatment with (-)-α-pinene. 
 
 
1.3  THE RESEARCH HYPOTHESES 
 
• Prevalence of Campylobacter spp. in Slovenia is underreported; 
• Antibiotic resistant Campylobacter jejuni are more prevalent in specific clonal 
complexes; 
• Extracts of Alpinia katsumadai poses antimicrobial, resistance-modulatory and 
efflux-inhibitory activity; 
• (-)-α-pinene is inhibitor of Campylobacter jejuni efflux systems CmeABC and 
Cj1687; 
• Campylobacter jejuni uses multiple mechanisms of adaptation to (-)-α- pinene. 
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2  SCIENTIFIC PUBLICATIONS 
 
2.1  PUBLISHED ARTICLES 
 
2.1.1  The evidence for clonal spreading of quinolone resistance with a particular 
clonal complex of Campylobacter jejuni 
 
Dokaz za klonsko širjenje odpornosti proti kinolonom z določenim klonskim kompleksom 
bakterij Campylobacter jejuni 
 
 
 
Jasna Kovač, Neža Čadež, Marija Lušicky, Eva Møller Nielsen, Matjaž Ocepek, Peter Raspor, 
Sonja Smole Možina 
 
Epidemiology & Infection (2014), 142: 2595–2603 
 
 
 
Campylobacter is the most prevalent cause of bacterial gastroenteritis worldwide and it 
represents a significant public health risk, severity of which is becoming even higher due to 
its increasing resistance to clinically important quinolone and macrolide antibiotics. As a 
zoonotic pathogen Campylobacter is transmitted along the food chain and naturally cycles 
from environmental waters, feedstuff, animals and food to humans. We have determined 
antibiotic resistance profiles, as well as MLST and flaA-SVR types for 53 C. jejuni isolated 
in Slovenia from human, animal, raw and cured chicken meat and water samples. Twenty-
eight different sequence types, arranged in ten clonal complexes, three new allele types and 
five new sequence types were identified, indicating the relatively high diversity among a 
small group of strains. The assignment of strains from different sources to the same clonal 
complexes indicates their transmittance along the food supply chain. The most prevalent 
clonal complex (CC) among isolates was ST-21, which was also the genetic group with 95% 
of quinolone resistant strains. Based on the genetic relatedness of these quinolone resistant 
strains found with MAMA PCR and gyrA QRDR sequencing, we conclude that high 
resistance prevalence observed in our study indicates the local clonal spreading of quinolone 
resistance with the CC ST-21. 
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2.1.2  Anti-Campylobacter and resistance-modifying activity of Alpinia katsumadai 
seed    extracts 
 
Protimikrobno in odpornostno modulatorno delovanje izvlečkov semen rastline Alpinia 
katsumadai na bakterije Campylobacter 
 
 
Anja Klančnik, Barbara Gröblacher, Jasna Kovač, Franz Bucar, Sonja Smole Možina  
 
Journal of Applied Microbiology (2012), 113, 5: 1249-1262 
 
Aims: We tested extracts from Alpinia katsumadai seeds for anti-Campylobacter activity 
and investigated the roles of the CmeABC and CmeDEF efflux pumps in Campylobacter 
resistance to these natural phenolics. Additionally, we investigated an A. katsumadai 
ethanolic extract (AlpE) and other plant extracts as putative efflux pump inhibitors on 
Campylobacter isolates and mutants in efflux pump genes. 
Methods and Results: AlpE showed antimicrobial activity against sensitive and multidrug-
resistant Campylobacter isolates. CmeB inactivation resulted in the greatest reduction in 
resistance, while cmeF and cmeR mutations produced only moderate effects on minimal 
inhibitory concentrations (MICs). The chemical efflux pump inhibitors additionally reduced 
MICs in isolates and mutants, confirming that active efflux is an important mechanism in 
resistance to AlpE, with additional contributions of other efflux systems. A notable decrease 
in resistance to tested antimicrobials in the presence of subinhibitory concentrations of AlpE 
confirms its modifying activity in Campylobacter spp. 
Conclusions: AlpE is important anti-Campylobacter source of antimicrobial compounds 
with resistance-modifying activity. At least two of the efflux systems are involved in the 
resistance to A. katsumadai antimicrobial seed extracts. 
Significance and Impact of the Study: This is the first report of antimicrobial and resistance 
modifying activity of AlpE from A. katsumadai seeds, demonstrating its potential in the 
control of Campylobacter in the food chain. 
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2.1.3  Antimicrobial and resistance modulatory activity of Alpinia katsumadai seed 
extract, essential oil and post-distillation extract 
 
Protimikrobno in odpornostno modulatorno delovanje semenskega izvlečka, eteričnega 
olja in podestilacijskega izvlečka rastline Alpinia katsumadai 
 
 
 
Jasna Kovač, Neda Gavarić, Franz Bucar, Sonja Smole Možina 
 
Food Technology and Biotechnology (2014), 52, 2: 248-254 
 
 
Antimicrobial resistance of food-related bacterial pathogens is becoming a serious problem, 
especially after the emergence of multidrug-resistant strains. To overcome this problem, new 
and effective antimicrobials or resistance modulators are highly needed and plant kingdom 
represents a valuable source of these compounds. We investigated antimicrobial and 
resistance modulatory activity of the phenolic extract, essential oil and post-distillation 
extract of Alpinia katsumadai seeds against Campylobacter jejuni and Staphylococcus 
aureus. Among the tested plant formulations, A. katsumadai seed extract and post-
distillation extract showed moderate antimicrobial activity against C. jejuni, while S. aureus 
was more resistant. When evaluating resistance modulatory potential of A. katsumadai 
phenolicextract, essential oil and post-distillation extract in C. jejuni against ciprofloxacin, 
erythromycin, triclosan, bile salts and ethidium bromide, plant formulations exhibited 
modulatory activity in combination with all antimicrobials. Modulation of resistance was 
more strain- and antimicrobial-specific in S. aureus, but very efficient in the case of reduced 
resistance to bile salts. Essential oil from A. katsumadai seeds efficiently increased 
intracellular ethidium bromide accumulation and was thus confirmed as potential inhibitor 
of efflux pumps in C. jejuni and S. aureus. 
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2.1.4  Antibiotic resistance modulation and modes of action of (-)-α-pinene in 
Campylobacter jejuni  
  
Modulacija antibiotske odpornosti in načini delovanja (-)-α-pinena pri bakterijah 
Campylobacter jejuni 
 
Jasna Kovač, Katarina Šimunović, Zuowei Wu, Anja Klančnik, Franz Bucar, Qijing Zhang, 
Sonja Smole Možina 
Accepted for publication in PLoS one on 5 Mar 2015 
 
The aim of the study was to investigate the mode of action of (-)-α-pinene in terms of its 
modulation of antibiotic resistance in Campylobacter jejuni. Broth microdilution and 
ethidium bromide accumulation assays were used to evaluate the (-)-α-pinene antimicrobial 
activity, modulation of antimicrobial resistance, and inhibition of antimicrobial efflux. The 
target antimicrobial efflux systems were identified using an insertion mutagenesis approach, 
and C. jejuni adaptation to (-)-α-pinene was evaluated using DNA microarrays. Knock-out 
mutants of the key up-regulated transcriptional regulators hspR and hrcA were constructed 
to investigate their roles in C. jejuni adaptation to several stress factors, including osmolytes, 
and pH, using Biolog phenotypical microarrays. Our data demonstrate that (-)-α-pinene 
efficiently modulates antibiotic resistance in C. jejuni by decreasing the minimum inhibitory 
concentrations of ciprofloxacin, erythromycin and triclosan by up to 512-fold. Furthermore, 
(-)-α-pinene promotes increased expression of cmeABC and another putative antimicrobial 
efflux gene, Cj1687. The ethidium bromide accumulation was greater in the wild-type strain 
than in the antimicrobial efflux mutant strains, which indicates that these antimicrobial 
efflux systems are a target of action of (-)-α-pinene. Additionally, (-)-α-pinene decreases 
membrane integrity, which suggests that enhanced microbial influx is a secondary mode of 
action of (-)-α-pinene. Transcriptomic analysis indicated that (-)-α-pinene disrupts multiple 
metabolic pathways, and particularly those involved in heat-shock responses. Thus, (-)-α-
pinene has significant activity in the modulation of antibiotic resistance in C. jejuni, which 
appears to be mediated by multiple mechanisms that include inhibition of microbial efflux, 
decreased membrane integrity, and metabolic disruption. These data warrant further studies 
on (-)-α-pinene to develop its use in the control of antibiotic resistance in Campylobacter. 
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2.2 UNPUBLISHED WORK 
 
2.2.1  Modelling the prevalence of foodborne pathogens in EU countries 
 
2.2.1.1 Introduction 
 
As the prevalence of foodborne diseases is thought to be significantly underestimated, there 
is a need to evaluate the effectiveness of the reporting process in order to appreciate the real 
burden of disease. The prevalence of infectious intestinal disease is underestimated due to 
underreporting and underdiagnoses associated with passive surveillance, incorrect diagnosis 
and inefficient communication, as well as with the large number of cases with mild 
symptoms that do not seek medical help.  
 
Some (longitudinal) studies have attempted to reconstruct the surveillance pyramid for 
foodborne diseases by evaluating a few vital fractions (rates), which quantify the 
underdiagnoses and underreporting of the diseases. These fractions include the probability 
for a patient to visit a GP, the probability for a GP to submit a stool, the probability for a 
positive result and the probability for a positive result to be reported etc. The probability for 
diarrhoea case to seek medical help and for a GP to submit the patient’s stool sample for 
microbiological analysis are the most important components contributing to the overall 
notification fraction according to the data from previous studies (Haagsma et al., 2012; 
Scallan et al., 2011; Hall et al., 2008; Scallan et al., 2006; Michel et al., 2000).  Patients 
seeking medical help, as well as GP decision making, is influenced by the severity of 
symptoms and, in particular the appearance of bloody diarrhoea. Rates from cases with 
bloody diarrhoea or otherwise are often analysed separately (Haagsma et al., 2012; Scallan 
et al., 2011; Scallan et al., 2006). Although some studies report similar proportions of 
diarrhoea cases seeking medical attention despite the differences in structure and access to 
health care system, e.g. in Australia, Canada, Ireland and United States (Scallan et al., 
2005), others reveal significant differences in medical help seeking behaviour among 
countries within EU (Haagsma et al., 2012).  
 
2.2.1.2 Modelling the prevalence for foodborne pathogens 
 
Prevalence is normative, characterizing the rate of cases in a population at a specific time 
and it is therefore easy to visualize and to compare different values. Prevalence in a 
population can be estimated from finite samples.  Reported cases of food borne illness occur 
according to a binomial process with prevalence taking to role of the binomial probability it 
is therefore convenient to represent uncertainty in prevalence by beta distribution. Because 
of the systematic relationship between the binomial process and a beta distribution 
(conjugacy) existing belief about the prevalence can be systematically updated given data 
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from successive finite samples. Bayes’ theorem can be used to express how to change a 
prior belief by taking evidence into account. Parameters affecting the prevalence for 
reporting of food borne illness by general practitioners (GPs) can be visualized by 
construction of a graphical representation. Since different parameters affecting the process 
of reporting are involved in cases of hospitalization, these have to be acknowledged with a 
separate branch in the graphical model. Because of the differences in symptoms and severity 
of the disease caused by different pathogens, as well as the differences in medical and 
reporting practice among European Union Member States (EU MSs), some of the 
parameters are dependent of the country and others of the pathogen.  
 
2.2.1.3  The MedVetNet model 
 
Haagsma et al. (2012) have built a probabilistic model for prediction of the reporting of 
prevalence for seven foodborne pathogens in seven EU MSs, including Denmark, Germany, 
Italy, Netherlands, Poland, Sweden, and United Kingdom. They included Campylobacter 
spp., Salmonella spp., Yersinia enterocolitica, Shigella spp., Shiga-toxin producing 
Escherichia coli O157(STEC), enteropathogenic Escherichia coli (EPEC), and 
Cryptosporidium spp. in their model. The Haagsma model acknowledges that general 
practitioner (GP) cases occur in a separate branch from hospitalized cases and consists of a 
series of country-specific and pathogen-specific parameters. The model also distinguishes 
the cases involving bloody diarrhoea from those with non-bloody diarrhea and addresses 
them independent of one another. The country-specific parameters used in the model were 
obtained from a variety of sources including expert opinions and harmonized longitudinal 
surveys of acute gastroenteritis incidence in the community. 
The MedVetNet model concerns the probability for reporting of a case of gastroenteritis. 
The total probability is constructed from the probability for general practitioner cases (PGP) 
and the probability for hospitalized cases (PH).  Each probability is the product of several 
parameters 
 
PGP = a* (1-pH) c* f j h = a* (1 – pH)                                …(1) 
 
PH = a* pH e g j i = a*  pH o                                       …(2) 
 
a* = k a + (1 – k) b                                             …(3) 
 
c* = k c + (1 – k) d                                             …(4) 
 
 
Where a* is the probability for a gastroenteritis case to consult a general practitioner and c* 
and e are probabilities for a stool sample to be submitted for the laboratory analysis, j is the 
sensitivity of laboratory analysis and i and h the probabilities for a positive result to get in 
the records. 
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The probability that a practitioner refers a case for hospitalization, pH, can be related to the 
fraction of reports that are associated with a hospital setting (fH) according to 
 
 
fH  = opH / (n(1-pH) + o pH))                                         …(5) 
 
 
Then the total probability for a case to become a report is 
 
 
        PTOT = 1 / M = (a* on) / (nfH + o(1 – fH))                              …(6) 
 
 
As we can observe from the above described dependency, the multiplier M depends on the 
fractional, rather than absolute rate of hospital cases. 
 
Dependencies between the important parameters are summarized by the arrows in Figure 1, 
where country-specific parameters are marked by green colour and pathogen-specific 
parameters by pink colour. Each arrow in the model means one variable depends on its 
parents. The model builds up from the number of cases within a population to the number of 
cases that are included in the records – and hence gives the representation for the multiplier.  
 
Figure 1: Probabilistic graphical model for reporting foodborne disease prevalence 
Slika 1: Verjetnostni grafični model za poročanje prevalence bolezni, povezanih s hrano 
 
We start from a total number of GP cases in the population Npop and partition by taking into 
account the parameter k, which stands for the fraction of cases with bloody diarrhoea. In this 
case the dependency is multiplication. After this step, the model splits in two branches; one 
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describing the behaviour related to bloody diarrhoea cases on the left (Npop_B) and the one 
describing the non-bloody cases (Npop_O) on the right side of the graphical model. The 
next step adds in the parameters describing the probability for a diarrhoea case to visit a 
general practitioner, which is labelled as a in case of bloody diarrhoea and as b in case of the 
non-bloody diarrhoea. Following step is multiplication by parameters c or d, which stands 
for probability of submitting a stool sample for analysis for a patient with bloody or non-
bloody diarrhoea, respectively. At this point a new, separate branch acknowledging the 
hospital flow, which starts with the population NH, is introduced. The equivalent parameter 
for probability of stool submission is introduced to the model as parameter e for the 
hospitalized patients. After this point the two branches of GP cases reconnect (add) and the 
resulting distribution is multiplied by parameter f, which represents the probability of 
analysing for a particular pathogen. The equivalent parameter introduced to the hospital 
branch of the model is labelled as g. The next parameter, j, describes the sensitivity of 
laboratory analysis for each individual pathogen and is common to both branches of the 
model. The terminal parameters h and i describe the probability for reporting the positive 
laboratory result to the authorities in case of GP consultation or hospitalization, respectively. 
The final distributions Npop_R and NH_R combine to give the total number of reports and 
therefore describe the number of cases of foodborne disease that get in the official records. 
In turn Npop and NH combined with the total number of reports can be transformed into a 
multiplier (M) that quantifies the efficiency of the reporting process. The multiplier can be 
used to calculate the prevalence of a particular disease (associated with a particular pathogen 
in a MS) based on the number of official reports. In the MedVetNet model each of 37 
different scenarios is quantified. 
 
2.2.1.4  The parameter uncertainty 
 
In order to evaluate the uncertainty associated with the multiplier each parameter of the 
model includes its own uncertainty (as a distribution) and the multiplications are carried out 
throughout the model by using parameter probability density functions, rather than point 
values. In that way it is possible to follow the contribution of uncertainty for each new 
parameter introduced to the model. The probability density distributions are informative of 
any unusual situations occurring in the model, which could not be observed from a simple 
median value of parameters.  
We have evaluated the role of parameter uncertainty by comparing the multiplier values 
(MMed) that are obtained as point values with information on parameter location alone, and 
the median of the multiplier distributions (%50(MMC)) when associated uncertainty is 
included by using Monte Carlo simulations (Table 1).  
As observed from the ratio between %50(MMC) and MMed, the values obtained from median 
parameter values turn out to be very good approximations of multipliers in most cases. 
When the parameter uncertainty increases, the median value is no longer useful, as observed 
in the case of STEC. The difference between the multiplier distribution and the multiplier 
median value in this case is substantially different, which indicates an anomalous situation.  
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Table 1: Median multiplier values for prevalence of foodborne disease established from Monte Carlo 
simulations and point values obtained from median values of parameters  
Preglednica 1: Mediane množiteljev prevalence patogenov povezanih s hrano, pridobljene z Monte Carlo 
simulacijami in točkovne vrednosti median posameznih parametrov 
Median Multiplier %50(MMC) MMed MMed/%50(MMC) 
UK Campylobacter 52.15 52.37 1.00 
UK Salmonella 39.71 38.67 0.97 
UK Yersinia 2185.99 2279.13 1.04 
UK Shigella 61.04 59.75 0.98 
UK STEC 1602.41 1504.42 0.94 
UK Cryptosporidium 92.91 94.68 1.02 
NL Campylobacter 49.41 49.08 0.99 
NL Salmonella 19.80 18.69 0.94 
NL Yersinia 45.74 43.59 0.95 
NL Shigella 52.33 49.96 0.95 
NL STEC 88.97 68.86 0.77 
NL Cryptosporidium 2085.10 2078.35 1.00 
DE Campylobacter 9.29 9.32 1.00 
DE Salmonella 6.69 6.52 0.97 
DE Yersinia 13.03 12.57 0.97 
DE Shigella 10.56 10.42 0.99 
DE STEC 23.02 19.33 0.84 
DE EPEC 34.09 31.06 0.91 
DE Cryptosporidium 101.43 92.49 0.91 
DK Campylobacter 29.36 29.23 1.00 
DK Salmonella 16.63 14.77 0.89 
DK Yersinia 20.12 19.48 0.97 
DK Shigella 29.63 27.90 0.94 
DK STEC 32.75 23.40 0.71 
DK EPEC 102.71 87.17 0.85 
IT Campylobacter 90.66 86.49 0.95 
IT Salmonella 16.73 14.66 0.88 
PL Campylobacter 295.91 247.09 0.84 
PL Salmonella 35.01 32.52 0.93 
PL Yersinia 227.78 199.87 0.88 
PL Shigella 58.03 53.05 0.91 
SE Campylobacter 17.14 16.33 0.95 
SE Salmonella 10.08 8.96 0.89 
SE Yersinia 13.66 12.40 0.91 
SE Shigella 18.06 16.08 0.89 
SE STEC 13.35 9.85 0.74 
%50(MMC) median multiplier values established from Monte Carlo simulations, MMed multiplier values 
established from median values of model parameters, MMed/%50(MMC) the ratio of multiplier values established 
from median values and Monte Carlo simulations 
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The analysis of the data shows that the differences arise from a considerably higher 
proportion of bloody diarrhea within the population (k) for STEC, in comparison to other 
pathogens. Consequently the importance of parameters a and c is increased. Since those are 
associated with notably higher uncertainty than parameters b and d, the median value no 
longer serves as a good approximation for the multiplier. An example of a well-defined 
distribution of the multiplier for Campylobacter in UK and a highly uncertain distribution 
for the multiplier for STEC in UK is presented in Figure 2. 
 
 
Figure 2: The distribution of prevalence multipliers for Campylobacter and STEC in UK 
Slika 2: Porazdelitev množiteljev prevalence za Campylobacter in STEC v Velki Britaniji 
 
2.2.1.5  Sensitivity of the model  
 
In order to evaluate the robustness of the model, it is important to identify the parameters 
that have the greatest impact on the model output by performing a sensitivity analysis. Since 
testing the sensitivity of the parameter distributions is highly complex, we have simplified 
the approach by using the model that is based on median values. When operating with 
numbers, such as median values, the sensitivity of multiplier (M) is a derivative dM/dp with 
respect to parameter value (p), for each individual parameter. A large derivative indicates 
strong sensitivity of a model with respect to the tested parameter, meaning that a minor 
change in the parameter value will substantially increase the multiplier. When the derivative 
is negative, the model output will decline when parameter value is increased. 
For easier comparison of the parameter sensitivity values, we have analysed the fractional 
rather than absolute increase in multiplier values by using (1/M) dM/dp. Furthermore, in 
order to easily compare all the parameters on a single scale, we have followed the variation 
of fractional changes in M with fractional changes of each individual parameter (p/M) 
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dM/dp, which are presented in Table 2. When normalized sensitivity of the parameter is -1 a 
10% increase in the parameter value will result in 10% decrease in the multiplier value etc. 
Similarly, the sensitivity value -0.5 means that the 10% increase in the parameter value will 
result in a 5% decline of the multiplier value.  
Table 2: Normalized sensitivity values (1/M)  p dM/dp for parameters p = a – k of the prevalence model  
Preglednica 2: Normalizirane vrednosti občutljivosti (1/M) p dM/dp za parameter p = a – k modela prevalence 
    a b c d e f g h i j k 
UK CAMP -0.22 -0.78 -0.24 -0.74 -0.03 -0.97 -0.03 -0.97 -0.03 -1.00 -0.15 
UK SALM -0.45 -0.55 -0.47 -0.51 -0.02 -0.98 -0.02 -0.98 -0.02 -1.00 -0.30 
UK YERS -0.40 -0.60 -0.44 -0.56 0.00 -1.00 0.00 -1.00 0.00 -1.00 -0.27 
UK SHIG -0.31 -0.69 -0.34 -0.65 -0.01 -0.99 -0.01 -0.99 -0.01 -1.00 -0.21 
UK STEC -0.89 -0.11 -0.63 -0.07 -0.30 -0.70 -0.30 -0.70 -0.30 -1.00 -0.47 
UK CRYP -0.01 -0.99 -0.01 -0.99 0.00 -1.00 0.00 -1.00 0.00 -1.00 -0.01 
NL CAMP -0.44 -0.56 -0.60 -0.36 -0.05 -0.95 -0.05 -0.95 -0.05 -1.00 -0.85 
NL SALM -0.69 -0.31 -0.74 -0.15 -0.11 -0.89 -0.11 -0.89 -0.11 -1.00 -1.17 
NL YERS -0.66 -0.34 -0.79 -0.20 -0.01 -0.99 -0.01 -0.99 -0.01 -1.00 -1.18 
NL SHIG -0.56 -0.44 -0.72 -0.26 -0.02 -0.98 -0.02 -0.98 -0.02 -1.00 -1.05 
NL STEC -0.96 -0.04 -0.96 -0.02 -0.02 -0.98 -0.02 -0.98 -0.02 -1.00 -1.56 
NL CRYP -0.02 -0.98 -0.05 -0.95 0.00 -1.00 0.00 -1.00 0.00 -1.00 -0.06 
DE CAMP -0.24 -0.76 -0.22 -0.72 -0.06 -0.94 -0.06 -0.94 -0.06 -1.00 -0.15 
DE SALM -0.47 -0.53 -0.41 -0.47 -0.12 -0.88 -0.12 -0.88 -0.12 -1.00 -0.29 
DE YERS -0.42 -0.58 -0.38 -0.53 -0.09 -0.91 -0.09 -0.91 -0.09 -1.00 -0.26 
DE SHIG -0.33 -0.67 -0.31 -0.62 -0.07 -0.93 -0.07 -0.93 -0.07 -1.00 -0.21 
DE STEC -0.89 -0.11 -0.74 -0.09 -0.17 -0.83 -0.17 -0.83 -0.17 -1.00 -0.53 
DE EPEC -0.33 -0.67 -0.30 -0.61 -0.09 -0.91 -0.09 -0.91 -0.09 -1.00 -0.21 
DE CRYP -0.01 -0.99 -0.01 -0.96 -0.04 -0.96 -0.04 -0.96 -0.04 -1.00 -0.01 
DK CAMP -0.49 -0.51 -0.24 -0.73 -0.03 -0.97 -0.03 -0.97 -0.03 -1.00 -0.48 
DK SALM -0.73 -0.27 -0.46 -0.49 -0.05 -0.95 -0.05 -0.95 -0.05 -1.00 -0.75 
DK YERS -0.70 -0.30 -0.43 -0.54 -0.02 -0.98 -0.02 -0.98 -0.02 -1.00 -0.71 
DK SHIG -0.61 -0.39 -0.34 -0.63 -0.03 -0.97 -0.03 -0.97 -0.03 -1.00 -0.61 
DK STEC -0.96 -0.04 -0.88 -0.10 -0.02 -0.98 -0.02 -0.98 -0.02 -1.00 -1.09 
DK EPEC -0.61 -0.39 -0.34 -0.63 -0.02 -0.98 -0.02 -0.98 -0.02 -1.00 -0.61 
IT CAMP -0.22 -0.78 -0.90 -0.09 -0.02 -0.98 -0.02 -0.98 -0.02 -1.00 -0.94 
IT SALM -0.45 -0.55 -0.84 -0.03 -0.13 -0.87 -0.13 -0.87 -0.13 -1.00 -0.95 
PL CAMP -0.32 -0.68 -0.02 -0.88 -0.09 -0.91 -0.09 -0.91 -0.09 -1.00 -0.02 
PL SALM -0.57 -0.43 -0.06 -0.77 -0.17 -0.83 -0.17 -0.83 -0.17 -1.00 0.08 
PL YERS -0.53 -0.47 -0.06 -0.87 -0.08 -0.92 -0.08 -0.92 -0.08 -1.00 0.08 
PL SHIG -0.43 -0.57 -0.04 -0.82 -0.15 -0.85 -0.15 -0.85 -0.15 -1.00 0.00 
PL STEC -0.93 -0.07 0.00 0.00 -1.00 0.00 -1.00 0.00 -1.00 -1.00 -0.52 
PL EPEC -0.43 -0.57 -0.03 -0.72 -0.25 -0.75 -0.25 -0.75 -0.25 -1.00 -0.03 
SE CAMP -0.61 -0.39 -0.14 -0.81 -0.05 -0.95 -0.05 -0.95 -0.05 -1.00 -0.50 
SE SALM -0.82 -0.18 -0.30 -0.64 -0.06 -0.94 -0.06 -0.94 -0.06 -1.00 -0.64 
SE YERS -0.79 -0.21 -0.27 -0.68 -0.05 -0.95 -0.05 -0.95 -0.05 -1.00 -0.62 
SE SHIG -0.72 -0.28 -0.20 -0.75 -0.04 -0.96 -0.04 -0.96 -0.04 -1.00 -0.58 
SE STEC -0.98 -0.02 -0.63 -0.14 -0.23 -0.77 -0.23 -0.77 -0.23 -1.00 -0.70 
UK United Kindgdom, NL Netherlands, DE Germany, DK Denmark, IT Italy, PL Poland, SE Sweden, NR 
number of reported cases, NH number of hospitalized cases 
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As observed from the values from Table 2, the most sensitive parameter is the one for the 
laboratory analysis for each individual pathogen (j), followed by f and h - the probabilities 
for analysing a pathogen and reporting the positive result, respectively. The model is also 
highly sensitive for changes in probability for a non-bloody case of diarrhoea to visit a GP 
(b) and probability for submitting a stool sample for analysis for a patient with non-bloody 
diarrhoea (d). Table 2 also shows that, for STEC, the parameters a and c, are sources of 
sensitivity corresponding with the higher rate for bloody diarrhoea (see above). Table 2 also 
indicates some national differences; for Germany and the UK the multiplier is significantly 
more sensitive to parameters b and d (corresponding with non-bloody diarrhoea) but for The 
Netherlands, Denmark and Sweden the results are equally sensitive to parameters a and c. 
 
2.2.1.6  Additional models for country-specific parameters 
 
The data needed to define the key parameters contributing to the estimation of the real 
prevalence (i.e. a community case rate) is usually collected in the healthcare system by 
evaluating special cohort studies, such as the longitudinal study of infectious intestinal 
disease in the UK (Wheeler et al., 1999; Tam et al., 2011) or Sensor in Netherlands (Wit et 
al., 2001).  The cohort studies as these are broad undertakings over a long period of time that 
result in large quantities of collected data, however they are laborious and expensive and 
only wealthy countries can afford to carry out studies with this type of design. For this 
reason the data needed for modelling the community prevalence of foodborne pathogens in 
less wealthy European Union Member States (EU MSs) is sparse to non-existing.  
 
In order to implement the Haagsma model in other EU MSs, we have searched for the 
required data without success (by direct approach to food safety authorities in some cases). 
Since the data is not available, we have explored the possibility to use the published data 
from countries within the MedVetNet model to predict the country-specific model 
parameters for EU MSs which cannot afford comparable studies. In practice we aimed to 
predict the reporting efficiency, and hence the community prevalence, for Campylobacter 
spp. in Slovenia. To do this, we modelled the crucial country-specific parameters a, b, c, d 
and e using linear regression based on the existing data for seven foodborne pathogens in 
seven EU countries. Only common statistical data freely available for EU countries through 
Eurostat (Table 3) was used to construct a model for the parameter uncertainty distributions.  
The model parameter for the probability of a case of bloody diarrhea to visit a GP (a) was 
fitted to data on average traveling distance to a GP and the number of GPs per 100,000 
people in the country. The medical help seeking behavior in case of experiencing a severe 
form of gastroenteritis with blood in the stool was associated with the availability of the 
medical help, which is related to the number of general practitioners per member of the 
population and to the accessibility of the healthcare. 
Probability for a non-bloody case to visit a GP (b) was modelled using the data on total 
population in the country and the fraction of middle aged people (age 25 to 64), which was 
believed to influence the medical seeking behaviour in case of gastroenteritis of low 
severity.  
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Table 3: Statistical data extracted from Eurostat (2014) that was used for linear regression fitting of the 
additional models for prediction of prevalence of foodborne diseases 
Preglednica 3: Statistični podatki, izvlečeni iz Eurostata (2014) in uporabljeni za prileganje dodatnih modelov 
za napoved prevalence bolezni, povezanih s hrano z linearno regresijo 
  D/GP GPs Pop fMA (%) GNI pC *RL fCE (%) PuF (%) 
THE/ 
capita PrF (%) 
PL 4.2 46.2 38564000 58.6 20450 16 28.6 71.6 1423 28.4 
SE 8.6 63.1 9591000 51.2 42350 21 35.6 78 3870 22 
DK 11.2 60.9 5612000 52.2 42330 14 35 84.3 4564 15.7 
UK 2.2 79.9 64231000 52.8 36970 8 34.2 96.9 3322 3.1 
IT 2.3 95.1 59626000 55.7 32350 20 34.3 57.1 3130 42.9 
NL 1.4 125 16798000 54.1 43770 30 33.8 70.7 5122 29.3 
DE 1.7 155.4 82141000 55.2 40170 16 33.9 77.5 4371 22.5 
SI 4.4 51 2062000 58.9 26040 9 30.5 80.8 2551 19.2 
PL Poland, SE Sweden, DK Denmark, UK United Kingdom, IT Italy, NL Netherlands, DE Germany, D/GP 
distance to GP, GPs number of GPs/100,000, Pop population, fMA fraction of middle aged people, GNI pC 
Gross national income per capita, RL number of regional laboratories, fCE fraction of children and elderly, 
PuF public funding of healthcare system, THE/capita total health expenditure per capita, PrF private funding of 
healthcare system. *Data obtained from the national public health institutes web pages. 
 
The parameter c, which describes the probability for a stool sample, from a case with bloody 
diarrhoea,   to be submitted for laboratory analysis by a GP, was modelled using data on 
gross national income (GNI) per capita and the number of regional labs. The wealth of the 
country was believed to affect a GP's decision making when considering sending the bloody 
stool sample for analysis. The availability and geographical remoteness and capacities of 
public health laboratories were also believed to play an important role in assessing the value 
of this parameter. 
The probability for a GP to submit a sample, from a non-bloody case,  for laboratory 
analysis (d) was modelled based on the data for the  fraction of children (0-14 year old) and 
elderly (>65 year old), which represent the most vulnerable groups, and the share of public 
funding of the healthcare system.  
The probability for a stool sample of a hospitalized patient being submitted (e) was 
modelled using data on total health expenditure per capita and on the share of private 
funding in the healthcare system. Most of the evidence indicates that the value of the 
multiplier is quite insensitive to the cases that are treated in hospital (see the final column in 
table 2). 
The parameters were modelled using the following expression: 
 
z = (α x/δ x) + (β y/δ y) - ((α<x>/δ x) + (β<y>/δ y)) + γ	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  …(7)	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where z is the median value of the parameter being estimated, x and y are the variables listed 
in the Table 2, and α, β and γ are fitting coefficients established by least squares fitting to the 
existing data from seven EU MSs published by Haagsma et al., 2012 (Table 3). The fitting 
procedure was completed using the SOLVER add in for Microsoft Excel. Model fits are 
presented in Figure 3a-e. 
 
 
Figure 3: Additional models for parameters a (probability for a case of bloody diarrhoea to visit general 
practitioner), b (probability for a case of non-bloody diarrhoea to visit general practitioner), c (probability for 
submitting a stool for a case of bloody diarrhoea), d (probability for submitting a stool for a case of non-bloody 
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diarrhoea) and e (probability for submitting a stool for hospitalized case). The probabilities from Haagsma 
model were fitted to common population and healthcare statistic data using linear regression. The error bars 
indicate the maximal uncertainty associated with the Haagsma model values. 
Slika 3: Dodatni modeli parametrov a (verjetnost obiska zdravnika v primeru krvave diareje), b (verjetnost 
obiska zdravnika v primeru nekrvave diareje), c (verjetnost odvzema vzorca v primeru krvave diareje), d 
(verjetnost odvzema vzorca v primeru nekrvave diareje) in e (verjetnost odvzema vzorca pri hospitaliziranem 
primeru). Verjetnosti iz modela Haagsma so bile prilegane na splošno dostopne prebivalstvene in javno-
zdravstvene podatke z uporabo linearne regresije. Napaka prikazuje maksimalno negotovost povezano z 
vrednostmi v modelu Haagsma. 
 
The values in the chart represent the each individual parameter’s values for seven EU 
countries – Poland, Sweden, Denmark, United Kingdom, Italy, Netherlands, and Germany - 
presented as numbers 1-7 on the x axis, respectively. The lines connecting the values serve 
only for visualization. 
Based on the median values of parameters a – e obtained using the above described 
additional models (built from data for 7 EU MSs), we have calculated the beta distribution 
parameters α1 and α2 for each of the additional models that correspond with Slovenia in 
order to attribute the associated uncertainty using Monte Carlo simulations. For each model 
parameter the beta distribution exponents were calculated according to the following 
equations 
 
α1 = (µ2 / δ2) (1 - µ)                                       …(8) 
α2 = (α1 (1-µ)) / µ or ((µ (1- µ2)/ δ2                         …(9) 
 
where α1 and α2 are parameters defining the beta distribution, µ is median and δ is standard 
deviation (Table 3). The standard deviations used in the calculations were maximal standard 
deviations for each of the parameters from the Haagsma study.  
 
Table 4: Parameters of additional models for prediction of prevalence of foodborne diseases 
Preglednica 4: Parametri dodatnih modelov za napoved realne prevalence bolezni povezanih s hrano 
  a b c d e 
α 0.2602 0.0532 0.0573 0.0836 0.5842 
β 0.1688 0.0468 0.1504 0.0546 0.1485 
γ 0.4843 0.2043 0.4329 0.1886 0.7457 
M 0.3038 0.2248 0.1458 0.1047 0.5842 
α1  2.86 13.54 1.07 2 8.4 
α2 6.54 150.11 6.29 17.13 5.98 
α, β, γare fitting coefficients , a – e are parameters of the prevalence model, M is median value (for Slovenia), 
α1 and α2 are parameters defining beta distributions of additional models (for Slovenia) 
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Monte Carlo simulations of modelled parameters were used to estimate beliefs about 
prevalence of Campylobacter in Slovenia, but these could be obtained for prediction of any 
of the seven foodborne pathogens in any of the EU MSs.  
 
4: The probability distribution of prevalence multiplier for Campylobacter spp. cases in Slovenia. 
Slika 4: Verjetnostna porazdelitev množiteljev prevalence za primere Campylobacter spp. v Sloveniji. 
 
The obtained median multiplier for Campylobacter GP cases in Slovenia when 
acknowledging modelled parameters a – e was 181.3. As observed from the figures 4, there 
is a high uncertainty attached to the estimation. 
A more complete analysis might use models fitted to only part of the MedVetNet data and 
use the remainder as a validation but it is clear from this analysis that there may be 
opportunities to establish beliefs, concerning community prevalence of infectious intestinal 
disease, without performing expensive community wide studies.   
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2.2.2  Clonal expansion of quinolone resistance among clinical Campylobacter isolates 
from Oxfordshire, United Kingdom 
 
2.2.2.1 Introduction 
 
Campylobacter spp. as the most prevalent bacterial cause of foodborne gastroenteritis 
represents a serious public health burden in UK, as well as in other EU countries, with C. 
jejuni being responsible for a vast majority of the cases (EFSA, 2014a). The disease itself is 
usually self-limiting, but the need for antibiotic treatment arises in more severe cases. 
Currently, macrolide and quinolone antibiotics are recognized as the drugs of choice for 
clinical treatment of campylobacteriosis. While the resistance to macrolides is successfully 
controlled, the prevalence of quinolone resistance was reported to rapidly increase over the 
last decade (Cody et al., 2010b; EFSA, 2014b). Although the use of quinolones as growth 
promoters of food production animals in EU was banned in 2006, they are still allowed to be 
used as therapeutics in poultry, which is recognized as the main source of human 
Campylobacter infections  (Wilson et al., 2008; Mullner et al.., 2009; Sheppard et al., 2009; 
WHO, 2011). Since the quinolone resistant C. jejuni mutants have better colonization fitness 
in chicken host, compared to the quinolone susceptible strains (Luo et al., 2005), the 
inappropriate use of quinolones in veterinary medicine can result in rapid selection of 
resistant isolates in animal reservoir (van Boven et al., 2003). The introduction of quinolone 
antibiotic to the farm environment would expect to substantially decrease the genetic 
variability of Campylobacter population within the farm by selecting for only the handful of 
the fittest resistant genotypes. Transmission of those from animals to humans through the 
food production chain is thereafter essentially unavoidable and leads to decreased efficacy 
of quinolones in human clinical treatment. 
 
There are several different mechanisms contributing to the quinolone resistant phenotype in 
Campylobacter. The most widely recognized is the mutation Thr86Ile in the quinolone 
resistance determining region (QRDR) of the DNA gyrase subunit A gene (gyrA), although 
several other resistance-conferring mutations on positions 70, 85, 86, and 104 within this 
region have been reported to date (Wieczorek and Osek, 2013). The mutations in the gyrA 
gene were observed to occur at frequency as high as 10-6, however the rate was shown to 
reach 100-fold reduction in mutants lacking the mfd gene (Han et al., 2008). Apart from 
point mutations, resistance is conferred also through antibiotic efflux provided by the 
activity of Campylobacter principal efflux pump CmeABC (Jeon and Zhang, 2009). 
 
Recently, several reports have demonstrated the clustering of quinolone resistant 
Campylobacter isolates within certain lineages (Kittl et al., 2013; Wimalarathna in sod., 
2013), indicating the local clonal expansion of quinolone resistant isolates based on the 
MLST typing. Moreover, the genetic relatedness of QRDR among those clustering within 
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the specific clonal complex provided further evidence for clonal nature of the quinolone 
resistance spreading (Kovač et al., 2014). The sequencing of QRDR region was found to be 
also a useful genotyping approach informative of the isolate’s ecological niche. When used 
together with MLST, it increased the discriminatory power and improved the source 
attribution (Ragimbeau et al., 2014).  
 
In present study we exploited the existing whole-genome sequence data of 1727 
Campylobacter spp. isolated from humans in Oxfordshire, UK from June 2011 to June 2013 
to characterize the quinolone resistance spreading using the typing and phylogenetic data. 
We have investigated the prevalence of genotypic quinolone resistance, as determined based 
on the presence of previously reported resistance conferring mutations within the QRDR 
region. The inferred genotypic resistance information was used to assign the resistance 
phenotype to gyrA alleles deposited in the PubMLST database and thereby predict the 
quinolone resistance phenotype of investigated isolates. The comparative analyses based on 
the variability within the gyrA, mfd and cmeB genes were carried out and clonal expansion 
of resistant genotypes was investigated by analysing the clustering of gyrA types among the 
established core genome phylogenies within the individually analysed groups of isolates.  
 
2.2.2.2 Materials and methods 
 
Isolates and whole genome sequence data 
 
The publicly available whole-genome sequence data for Campylobacter jejuni and 
Campylobacter coli strains isolated from human stool samples submitted to the 
microbiology laboratory of John Radcliffe Hospital in Oxford between June 2011 and June 
2013 were included in the study. The data was produced by the research groups from 
Department of Zoology from University of Oxford (Maiden group) and John Radcliffe 
Hospital, and was deposited to the online database PubMLST 
(http://pubmlst.org/campylobacter; Jolley and Maiden, 2010). 
 
Variability of gyrA gene and genotypic quinolone resistance 
 
The variability of gyrase subunit A gene (gyrA) among the investigated isolates was 
evaluated by extracting the arbitrary integer identifier of CAMP0950 (gyrA) locus 
automatically assigned to each isolate deposited in the PubMLST database. To the date of 
analysis (2nd October 2014), there were 554 unique gyrA allele variants defined in the 
Campylobacter locus/sequence definition database pubMLST (Jolley and Maiden, 2010). 
 
Literature search was carried out to identify 9 mutations on 5 positions (A70T, D85Y, T86I, 
T86K, T86A, T86V, D90N, D90Y and P104S) in quinolone resistance determining region 
of the gyrA gene, which were previously associated with phenotypic resistance to quinolone 
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antibiotics (Wieczorek and Osek, 2013). Resistant or susceptible phenotypes were assigned 
to the 554 unique gyrA allele types defined in Campylobacter locus/sequence definition 
database based on the presence of any single or a combination of listed mutations within the 
QRDR. The defined resistant gyrA genotypes were used to predict the phenotypic resistance 
of the investigated isolates. 
 
Comparative analysis of quinolone resistance associations 
 
The distribution of resistant and susceptible gyrA alleles among investigated group of 
isolates was analysed, and the associations of specific mfd and cmeB alleles with genotypic 
resistance was explored. Furthermore, the association of quinolone resistance with specific 
clonal complexes (CCs) and sequence types (STs) within the highly resistant clonal 
complexes were evaluated. 
 
Genome Comparator analyses 
 
In order to investigate the clonal expansion of the quinolone resistance among isolates from 
highly resistant clonal complexes, we have inferred their phylogenetic relationships based 
on the core genome using the Genome Comparator module of the BIGSdb (Jolley and 
Maiden, 2010). The pairwise allelic differences were computed for a core genome defined as 
all the shared loci within the analysed group of isolates. The established distance matrices 
were visualized in SplitsTree version 4.12.8 (Huson and Bryant, 2006) by employing the 
Neighbor-net algorithm (Bryant in Moulton, 2004), which accounts for the recombination 
and horizontal gene transfer and does not assume the tree-like hierarchy. This makes it more 
appropriate for visualisation of frequently ambiguous phylogenetic relationships among 
highly recombinant species.  
 
The gyrA alleles were mapped over the phylogenetic trees comprising the isolates from each 
individual analysed clonal complex, in order to identify the clustering of specific resistance-
associated gyrA alleles indicative of clonal expansion of the resistance. 
 
Statistical analyses 
 
Association of quinolone resistance with specific MLST clonal complexes and sequence 
types, as well as with gyrA, mfd, and cmeB allele types was evaluated using Pearson’s chi-
square or Fischer’s exact, when appropriate, in StataIC 10 (StataCorpLP, Texas). The cut-
off for statistical significance was set at p<0.5. 
 
2.2.2.3 Results and Discussion 
Isolates 
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In total 1727 Campylobacter jejuni and Campylobacter coli strains isolated from human 
stool samples submitted to the microbiology laboratory of John Radcliffe Hospital in Oxford 
between June 2011 and June 2013 were included in the study. The Oxfordshire area 
comprises the population of approximately 630,000 and is a representative sample (1%) for   
the entire United Kingdom.   
 
The 880 of strains were isolated in year 1 (June 2011 to June 2012) and 847 in year 2 (June 
2012 to June 2013). The whole genome sequencing was performed and resistance to 
ciprofloxacin determined for each of the isolates. Ten isolates from year 1 and 6 isolates 
from year 2 were excluded from the analysis due to the incomplete data (missing MLST ST, 
MLST rST and/or any of the investigated alleles), resulting in a final set of 1711 isolates 
being analysed. 
 
Variability of gyrA and genotypic quinolone resistance 
 
In total 328 unique gyrA variants were identified in 1711 isolates included in the analysis, 
176 in year 1 and 152 in year 2, indicating a slightly higher diversity among isolates from 
year 1.  
 
Genotypic quinolone resistance was determined based on the presence of any single or a 
combination of different quinolone resistance determining mutations within the QRDR, as 
identified in the literature search. The mutation T86I was identified as the principal mutation 
responsible for high levels or quinolone resistance, while eight other mutations (A70T, 
D85Y, R86K, T86A, T86V, D90N, D90Y and P104S) were previously reported to be 
associated with quinolone resistance, as well. In this study we have identified another 
mutation, P104T, which was previously not reported elsewhere. This particular mutation 
was found in two isolates of C. jejuni with MLST sequence type 50, and in both cases co-
existed with the predominant resistance conferring mutation T86I, which disabled us to 
evaluate its sole contribution to the resistant phenotype. 
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Figure 5: The gyrA allele distribution among Campylobacter jejuni and Campylobacter coli human isolates 
from John Radcliffe Hospital catchment area, Oxfordshire, Oxford, between June 2011 and June 2013. 
Slika 5: Porazdelitev alelov gyrA med humanimi izolati Campylobacter jejuni in Campylobacter coli iz 
bolnišnice John Radcliff v Oxfordshiru v Oxfordu med junijem 2011 in junijem 2013. 
 
First and second column of each allele represents the number of isolates carrying this allele 
in year 1 and 2, respectively. Grey columns represent quinolone susceptible genotypes, 
black columns quinolone resistant genotypes. Only the gyrA alleles with 10 or more 
representative isolates per year are presented. 
 
In order to assign the resistant genotype to the analysed isolates, we first defined it for 554 
existing gyrA allele types in the Campylobacter locus/sequence definition database at 
pubMLST.org. The 253 of those were determined as resistant and 301 as susceptible. As 
presented in the Figure 1, the most prevalent gyrA alleles associated with resistance were 20, 
57 and 5, while others were present in fewer than 15 isolates per year.  
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Figure 6: SplitsTree phylogenetic network build using Neighbor-net algorithm based on the unique gyrA allele 
sequences identified in human isolates from John Radcliffe Hospital catchment area, Oxfordshire, Oxford, 
between June 2011 and June 2013. 
Slika 6: Filogenetska mreža zgrajena 2013 v programu SplitsTree z algoritmom Neighbor-net na podlagi 
unikatnih alelnih variant gena gyrA med humanimi izolati iz bolnišnice John Radcliff v Oxfordshiru v Oxfordu 
med junijem 2011 in junijem. 
 
The phylogenetic network demonstrates the clear discrimination between the Campylobacter 
jejuni and Campylobacter coli isolates based on the gyrA sequence variability, with the 
exception of the hybrid allele type 363 marked with red.  
 
The Neighbor-net analyses of unique gyrA sequences in SplitsTree demonstrated the clear 
split between the two analysed species, C. jejuni and C. coli, with exception of one C. coli 
strain (ID 25067, ST 827) that carried the hybrid gyrA allele 363 associated with quinolone 
resistance (Figure 2). The hybrid allele appears to be the result of recombination between C. 
coli allele 66 and C. jejuni allele 5, both associated with resistance and frequently found 
among analysed isolates (Figure 1). 
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Based on the presence of resistant gyrA variants among the 1711 analysed isolates, we 
determined 37.9% (N=330) of isolates from year 1 and 38.6% (N=325) isolates from year 2 
as resistant to quinolones. The prevailing mutation in resistant isolates was T86I, and was 
absent from only two resistant isolates in year 1 and three resistant isolates from year 2. In 
all cases it was substituted by the mutation T86A. The coexistence of two resistance-
conferring mutations was observed in 6 isolates from year 1 and in a single isolate from year 
2. The obtained results clearly confirm the mutation T86I as the major quinolone resistance-
conferring mutation in Campylobacter.  
 
MLST and clonal complexes 
 
The MLST profiles for 1711 isolates were generated from WGS data, identifying 206 and 
171 STs in years 1 and 2, respectively. These were assigned to 32 clonal complexes in year 
1 and 31 clonal complexes in year 2. In year one 49/870 (5.6%) of the isolates were 
unassigned to any of the existing clonal complexes and in year two 40/841 (4.8%) were left 
unassigned.  
 
Comparative analysis of quinolone resistance associations 
The prevalence of resistant isolates, as determined based on the gyrA allele types, was 
investigated among clonal complexes. The clonal complexes ST-464 and ST-354 had the 
highest proportions of quinolone resistant isolates and the correlation with resistance was 
statistically significant (p<0.001) in both years (Figure 3). In year 1 51/54 (94.4%) isolates 
from CC ST-464 were resistant to quinolones, while in year 2 the proportion decreased 
(66/75, 88%), however the total prevalence of the clonal complex increased by 39%. The 
rise in prevalence was observed also for clonal complex ST-354, of which 24 cases were 
recorded in year 1 and 30 cases in year 2. The prevalence of resistance in this clonal 
complex was 20/24 (83.3%) and 29/30 (96.7%) in year 1 and 2, respectively. The most 
common clonal complex, ST-21, was also observed to have high proportions of quinolone 
resistant isolates, however the correlation was not confirmed as statistically significant. Due 
to the possibility of a specific ST contributing to the high resistance rate within the clonal 
complex ST-21, we have further investigated the distribution of resistant isolates within the 
STs of this complex. Indeed the analysis confirmed the significance (p<0.05) of quinolone 
resistance with ST 50, where 38/57 (66.7%) and 31/60 (51.7%) of isolates were resistant in 
year 1 and 2, respectively. Breaking down the resistant clonal complexes ST-464 and ST-
354 revealed in both years fully resistant ST 5136 within clonal complex ST-464, giving the 
strong indication of clonal expansion of quinolone resistance with this ST. Furthermore, the 
ST 354 from clonal complex ST-354 had 16/17 (94%) resistant isolates in year 1 and was 
fully resistant in year 2.  
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Figure 7: The distribution of quinolone resistant Campylobacter jejuni and Campylobacter coli human isolates 
from John Radcliffe Hospital catchment area, Oxfordshire, Oxford, between June 2011 and June 2013 among 
major clonal complexes. The asterisk indicates the statistically significant correlation of quinolone resistance 
with particular clonal complex in both years. Only clonal complexes with 10 or more representative isolates 
per year are presented. 
Slika 7: Porazdelitev proti kinolonom odpornih humanih izolatov iz bolnišnice John Radcliffe v Oxfordshiru  v 
Oxfordu med junijem 2011 in junijem 2013 v glavne klonske komplekse. Zvezdica nakazuje statistično 
značilno povezavo med kinolonsko odpornostjo in klonskim kompleksom v obeh letih. Na sliki so prikazani 
samo klonski kompleksi z 10 ali več predstavniki. 
 
Clonal expansion was further examined by building the phylogenetic networks based on the 
core genome of isolates from clonal complex ST-464 (N=129), ST 354 (N=54) and ST-
21(N=391) and investigating the distribution of gyrA alleles among the established 
phylogenetic clusters. As observed from the Figure 4, there were clear indications of clonal 
expansion of quinolone resistant isolates within the clonal complexes ST-464 (A) and ST-
354 (B), while clonal structure of resistant isolates within clonal complex ST-21 (C) was 
less conspicuous.  
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Figure 8: The distribution of gyrA alleles over the phylogenetic clusters established from core genomes of 
isolates from A) clonal complex ST-464, B) clonal complex ST-354 and C) clonal complex ST-21.The blue 
colour represents quinolone susceptible genotypes and the red colour represents the quinolone resistant 
genotypes. 
Slika 8: Porazdelitev alelnih variant gena gyrA med filogenetskimi skupinami, pridobljenimi na podlagi 
primerjave jedrnih genomov izolatov iz A) klonskega kompleksa ST-464, B) klonskega kompleksa ST-354, C) 
klonskega kompleksa ST-21. Modra barva predstavlja na kinolone občutljive isolate, rdeča proti kinolonom 
odporne isolate. 
 
The quinolone resistant isolates assigned to clonal complex ST-464 clearly clustered in three 
clonal groups, all of them possessing the gyrA allele type 57 (p<0.001). The gyrA allelic 
structure was uniform in MLST sequence type 5136, unambiguously indicating the clonal 
development of this group of resistant isolates, while higher level of variability was found in 
ST 464. There, gyrA 57 was found in only 14/42 (33.3%) of the isolates, and the resistant 
isolates from ST 464 carrying the gyrA allele 57 formed 2 clusters, indicating the lower level 
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of clonality. The development of a single major group of resistant isolates in clonal complex 
ST-354 was associated with gyrA allele variant 20 (p<0.001) (Figure 4B).  
 
As demonstrated by the consistent clustering of the resistant isolates with ST 354 and gyrA 
20 within a single phylogenetic group, the high quinolone resistance rate in this clonal 
complex was acquired by clonal growing of the resistant population. In contrast to ST-464 
and ST-354, the phylogenetic structure of clonal complex ST-21 was substantially more 
diverse (Figure 4C). The resistance in ST-21 was associated with two gyrA variants – gyrA 5 
60/165 (36.4%) and gyrA 20 85/165 (52.5%) (p<0.01). The first variant appeared mostly 
among isolates of MLST ST 21, while the second was found among MLST ST 19, ST 2135, 
and ST 50. The ST 50 was the only one of those with statistically significant correlation with 
quinolone resistance. As presented on the Figure 4C, some level of clonal clustering was 
observed for resistant isolates from clonal complex ST-21, which carried gyrA variant 20, 
however based on the presented evidence the nature of the resistance spreading within the 
ST-21 remains disputable.  
 
Due to the previous reports of mfd gene contributing to the development of quinolone 
resistant mutations in Campylobacter (Han et al., 2008) we have investigated the link 
between specific mfd allele variants and quinolone resistance within our set of isolates. 
There were 182 unique mfd alleles identified in year 1 and 157 in year 2. The mfd alleles 
with 10 or more quinolone resistant representatives in each year, and with statistically 
significant association with quinolone resistance, were 1, 106, 39, 19, 31, and 111 (Figure 
5).  
 
Of those, the mfd allele 1 was associated with quinolone susceptibility in year 1, while mfd 
alleles 106, 39, 19, 31 and 111 were associated with quinolone resistance in both years 
(p<0.01). In each of those, the predominant proportion of resistant isolates carried a single 
resistance-associated gyrA variant. This was gyrA 57 in case of mfd 106, gyrA 20 in case of 
mfd 39, 19, and 111, and gyrA 59 in case of mfd 31 (Figure 4). The combination of mfd 19 
and gyrA 20 was typical for quinolone resistant isolates from CC ST 354, while the 
combination of mfd 39/111 and gyrA 20 was mostly found in quinolone resistant isolates 
from ST 50 (p<0.0001). The analysis of representative sequences of mfd alleles 1, 19, 39, 
106, and 11 revealed 39 variable nucleotides over the total length of 1892 bp. As expected, 
the nucleotide sequences of mfd alleles 39 and 111 (both typical for ST 50) were the most 
similar to each other, while the mfd 106 (common in STs 464 and 5136) was the most 
distinct from all others. 
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Figure 9: Distribution of gyrA alleles within the mfd alleles among Campylobacter jejuni and Campylobacter 
coli human isolates from John Radcliffe Hospital catchment area, Oxfordshire, Oxford, between June 2011 and 
June 2013, and their correlation with quinolone resistance.The mfd alleles with statistically significant 
correlation with quinolone resistance in both years are marked with asterisk. Resistant gyrA alleles are 
presented with red colour. Only the mfd alleles with 10 or more quinolone resistant representative isolates are 
presented. 
Slika 9: Porazdelitev alelnih variant gena gyrA znotraj posameznih alelov gena mfd med humanimi izolati 
Campylobacter jejuni in Campylobacter coli  iz bolnišnice John Radcliffe (junij 2011 -  junij 2013). Aleli mfd s 
statistično značilno povezavo s kinolonsko odpornostjo v obeh letih so označeni z zvezdico. Alelne variante 
gyrA, ki so značilne za proti kinolonom odporne seve, so označene z rdečo bravo. Na sliki so predstavljeni 
samo aleli mfd, ki so zastopani z 10 ali več izolati. 
 
Besides the resistance-conferring mutations in QRDR of gyrA gene, active efflux was 
reported to importantly contribute to the phenotypic resistance. We have analysed the 
variability and the distribution of the inner membrane transporter gene cmeB present in our 
set of isolates and the correlation of specific allele variants with quinolone resistance. The 
proportion of resistant and susceptible isolates within the seven cmeB alleles that had 10 or 
more resistant representative isolates are presented in Figure 6.  
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Figure 10: Distribution of cmeB alleles among Campylobacter jejuni and Campylobacter coli human isolates 
from John Radcliffe Hospital catchment area, Oxfordshire, Oxford, between June 2011 and June 2013, and 
their correlation with quinolone resistance. The white colour represents quinolone susceptible isolates and 
black colour quinolone resistant isolates. The cmeB alleles with statistically significant correlation with 
quinolone resistance or susceptibility in both years are marked with asterisk. Only the cmeB alleles with 10 or 
more quinolone resistant representative isolates are presented. 
Slika 10: Porazdelitev alelnih variant gena cmeB med humanimi izolati Campylobacter jejuni in 
Campylobacter coli  iz bolnišnice John Radcliffe v Oxfordshiru v Oxfordu (junij 2011 -  junij 2013) in njihova 
povezava s kinolonsko odpornostjo. Bela barva označuje isolate odporne proti kinolonom in črna barva isolate 
odporne proti kinolonom. Alelne variante gena cmeB, ki so statistično značilno povezane s kinolonsko 
odpornostjo ali občutljivostjo so označene z zvezdico. Na sliki so predstavljeni samo aleli cmeB, ki so 
zastopani z 10 ali več izolati. 
 
 Of those, 1, 113, 135, and 53 were significantly linked with quinolone resistance (p<0.001). 
On the other hand, allele 604, along with 94, 51, 5, 14, 24, and 35 was associated with 
quinolone susceptibility in both years (p<0.05). Comparison of variable nucleotides within 
the two groups of cmeB alleles reviled no obvious variable hot spots within the gene, as the 
variability was observed all over the sequence length. The Neighbor-net phylogeny analysis 
demonstrated that cmeB 35 and 135 cluster in a separate group, and that alleles 1, 14, and 94 
form an individual subgroup, suggesting that the resistant genotypes 135 and 1 were 
developed from susceptible allele types 35 and 14, and 94, respectively (data not shown).  
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3 GENERAL DISCUSSION AND CONCLUSIONS 
 
3.1  GENERAL DISCUSSION 
 
3.1.1  Underreporting of Campylobacter prevalence 
 
Campylobacteriosis is a leading zoonotic food-borne disease in Europe and around the 
world. Its yearly incidence in 2012 in Europe and Slovenia was 55.49 and 45.4/100.000, 
respectively (EFSA, 2014a; IVZ, 2012). These numbers are still thought to be strongly 
underreported, since most campylobacteriosis cases remain unrecognized by the surveillance 
system due to the mild self-limiting symptoms or undetermined cases of gastroenteritis. In 
Slovenia, as well as in other European countries, there is a trend of increasing 
campylobacteriosis incidence (EFSA, 2014a; IVZ, 2012). 
 
In order to evaluate the burden of the disease caused by Campylobacter spp. their true 
incidence needs to be estimated. This is thought to be much higher than reported due to 
under-diagnosis and underreporting. The under-diagnosis occurs because many cases who 
do not seek medical help are not acknowledged by the healthcare system, while the 
underreporting is a consequence of incorrect diagnosis, classification, notification or 
dissemination to surveillance authorities. All this depends on the pathogen and each 
individual country, since they have different availability of healthcare use, laboratory 
practice and surveillance system. 
 
To estimate the true prevalence of campylobacteriosis in Slovenia, we have modelled the 
EU country-specific and Campylobacter-country-specific parameters which can be used in 
the prevalence estimation of seven food-borne pathogens in any of the EU Member 
countries. Parameters were modelled based on published data for seven EU Member 
countries (Haagsma et al., 2012) using common statistical data available through Eurostat. 
 
We have identified the probability for a case of non-bloody diarrhoea to visit a GP to be the 
most sensitive parameter of the model predicting the real prevalence of campylobacteriosis. 
This was demonstrated with substantial changes in final multiplier occurring as a 
consequence of minor changes in this parameter. As finally observed, when calculating the 
multiplier of campylobacteriosis in Slovenia, the parameter d had strong influence on the 
uncertainty of the final multiplier, which was estimated to be 181.3. These results 
demonstrate that the cases of mild diarrhoea are the ones that contribute the most to the 
underreporting of food borne diseases. The underreporting due to this contributor is 
especially pronounced in the case of the diseases that evoke only mild diarrhoeal symptoms, 
such as campylobacteriosis. 
 
3.1.2  Transmission of C. jejuni from environment, along the food production chain, to 
humans 
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Campylobacter is colonizing the gut of many production animals, in which it rarely causes 
disease symptoms. The meat of these animals is therefore often contaminated during the 
slaughtering and serves as a vehicle of transmittance of this pathogen via food chain. It 
naturally cycles from environmental waters, feedstuff, animals and food to humans (Silva et 
al., 2011) and is known for its fast adaptation ability and genomic instability (Jayaraman, 
2011; Hänninen and Hannula, 2007; Wassenaar et al., 1998). When different reservoirs 
harbour strains with specific genotypes, it is therefore possible to determine the source of the 
infection using PFGE, MLST and/or fla typing (Sahin et al., 2012; Magnusson et al., 2010; 
Sheppard et al., 2009). Nevertheless, MLST has become the method of choice for 
Campylobacter genotyping. In combination with sequencing of the short variable region 
within the flagella-encoding flaB gene it allows further strain differentiation within the same 
MLST sequence types (ST) (Wirz et al., 2010).  
 
We have determined antibiotic resistance profiles, as well as MLST and flaA-SVR types for 
53 C. jejuni isolated in Slovenia from human, animal, raw and cured chicken meat and water 
samples. Twenty-nine different sequence types, arranged in eleven clonal complexes (CCs), 
three new allele types and five new sequence types were identified, indicating the relatively 
high diversity among a small group of strains. Twenty-three out of 29 STs appeared only 
once, which further confirms high genetic diversity. Sequence types belonging to clonal 
complexes ST-21 and ST-45 were previously confirmed to be predominant in European 
region and typical for poultry (Gripp et al., 2011; Wirz et al., 2010; Korczak et al., 2009) 
and were highly represented among isolates from poultry meat and faeces (63% and 75%) 
also in our study. All five isolates with the newly identified tkt allele type originated from 
the same region in Slovenia and were isolated from raw and cured chicken meat and human 
faeces, indicating chicken as the most probable source of human infection. The comparative 
analysis revealed some correlation between specific genotypes and their main sources of 
isolation. Majority of the human isolates (70%) were distributed into CC ST-21 and CC ST-
353 and most of the meat isolates (63%) in CC ST-21 and CC ST-45, while animal isolates 
were mostly (67%) assigned to CC ST-21 and CC ST-354 (Kovač et al., 2014a).  
 
Parallel to MLST typing, flaA typing was carried out, which was with 23 different genotypes 
found to be less discriminatory than MLST. The higher discriminatory power was also 
confirmed with higher Simpson’s diversity index for MLST (0.942), compared to flaA-SVR 
(0.928). The combination of both typing methods increased the discriminatory power to 
0.967. The most common flaA alleles were 36 (n=9/17%), 278 (n=8/15%) and 256 
(n=7/13%). All flaA allele types 256 and 36 were distributed in to CC ST-21, while most of 
the strains with allele type 278 were assigned to CC ST-353 as well as to CC ST-21 and CC 
ST-48. Cluster analysis of flaA SVR sequences revealed six major clusters at similarity level 
of 95%. Statistical analysis confirmed flaA allele type 36 (n=8/89%) as typical for animal 
isolates and type 278 as typical for meat isolates (n=5/63%) (Kovač et al., 2014a). 
 
The water isolates were genetically the most diverse group and two out of five could not be 
assigned to any existing clonal complex (Kovač et al., 2014a). With distinct sequence types 
they present an interesting group with little in common with isolates originating from biotic 
sources like humans, animals and meat.  
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3.1.3  Prevalence and epidemiological characteristics of Campylobacter antibiotic 
resistance 
 
The prevalence of antibiotic resistance among campylobacters is constantly increasing 
(EFSA, 2014b). As we have seen in the previous work, the contribution of environment to 
the resistance prevalence is neglegable (Kovač et al., 2014). On the other hand, the highest 
incidence of resistance is recorded among the livestock isolates (EFSA, 2014b; Kovač et al., 
2014). This is somewhat expected, due to the extensive use of antibiotics in the veterinary 
medicine (EMA, 2011a; EMA, 2011b). The problem is, that the resistance, together with the 
pathogen is transmitting along the food chain and, finally, compromising the effective 
treatment of human campylobacteriosis. 
 
The most problematic antibiotic from the resistance point of view is ciprofloxacin from the 
class of quinolones. This family of antibiotics is used in veterinary as well as human 
medicine. In order to elucidate the epidemiology of the quinolone resistance of C. jejuni, we 
have investigated how the antibiotic spreads among isolates from different sources from 
environment, livestock and human (Kovač et al., 2014a). We have included 52 strains 
isolated in Slovenia in the study, where we employed the MLST to determine the clonal 
structure of this group of isolates. Furthermore, we have determined their phenotypical 
antibiotic resistance against seven antibiotics (gentamicin, streptomycin, ciprofloxacin, 
tetracycline, erythromycin, nalidixic acid and chloramphenicol). We have recorded that the 
highest prevalence of resistance to both of the quinolone antibiotics, ciprofloxacin and 
nalidixic acid, confirming the development of cross-resistance among the antibiotics of the 
same class. The incidence of resistance to quinolones was the highest in isolates belonging 
to the MLST clonal complex 21, which was an indication of the clonal spreading of this type 
of resistance. The resistance of Campylobacter spp. to quinolone antibiotics is known to be 
provided by the point mutation within the quinolone resistance determining region (QRDR) 
of the gyrA gene (Iovine, 2013). Besides this, it was proven that the strains with this point 
mutation are more fit to survive and colonize the host, compared to the quinolone sensitive 
strains, even in the absence of the antibiotic selective pressure (Hyytiäinen et al., 2013; Luo 
et al., 2005). This striking finding has further strengthened our belief about the clonal spread 
of quinolone antibiotic resistance. We have approached this investigation using the QRDR 
typing of the phenotypically ciprofloxacin resistant strains. The comparative analysis has 
revealed that all the quinolone resistant strains from clonal complex 21 were assigned to the 
separate cluster based on the similarity within the gyrA gene. This was the final proof of the 
quinolone resistance clonality, which rejected the alternative hypothesis about the frequent 
individual mutation acquirement (Kovač et al., 2014a).  
 
Recently several other high-quality research works studying the similar topic were published 
and they all observed resistance to quinolones to be related to several clonal complexes, 
however, none of them provided the molecular evidence in form of genetic similarity in 
quinolone resistance determining region (Kittl et al., 2013; Wimalarathna et al., 2013; Stone 
et al., 2013; Wirz et al., 2010) 
Due to the fact that the group of analysed strains in our study was relatively small and 
considered to be local from the total EU aspect, analysis on expanded, international set of 
strains needed to be carried out in order to confirm that the observed trend is not only local. 
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For this reason we have exploited the publicly available Campylobacter jejuni and 
Campylobacter coli whole genome sequences deposited in PubMLST database for the 
analysis of the quinolone resistance spreading among human clinical isolates from 
Oxfordshire, UK. The 1711 isolates included in the final analysis were collected between 
June 2011 and June 2013. Firstly, the gyrA gene of the analysed isolates was curated and the 
arbitrary allele number was assigned to each locus variant. The genotypic resistance was 
then assigned to each unique gyrA variant based on the presence of the resistance-conferring 
mutations within the QRDR. We have found that the quinolone resistance was the highest 
within the ST 50 of clonal complex ST-21 (66.7% in year 1 and 51.7% in year 2), within the 
CC ST-354 (83.3% in year 1 and 96.7% in year 2) and CC ST-464 (94.4%in year 1 and 88% 
in year 2). In order to explore the nature of the resistance expansion, we have build the core-
genome phylogenies of isolates from clonal complexes ST-21, ST-354, and ST-464 and 
investigated the clustering of gyrA variants within the inferred phylogenetic networks. The 
distribution of gyrA allele variant 20, which was the main allele type associated with 
resistance in clonal complex ST-21, was observed in different clusters within the clonal 
complex, suggesting that it is not expanding clonally. On the other hand, the same gyrA 
variant clearly clustered within a major resistant group of isolates within the CC ST-354. 
Similarly, we observed the clustering of the isolates carrying the quinolone resistant gyrA 
allele 57 within a single group of CC ST-464, clearly indicating the clonal expansion of 
quinolone resistance with these two clonal complexes. 
 
The increase in the rate of the resistance-conferring mutations within the gyrA gene was 
previously associated with the presence of the mfd (mutation frequency decline) gene (Han 
et al., 2008), which has lead us to investigate how the variability within the mfd might 
influence the quinolone resistance. We found that the alleles 106, 39, 19, 31 and 111 were 
associated with quinolone resistance, and that certain gyrA variants are significantly 
associated with certain mfd variants, suggesting that these two genes are not evolved 
independently. Similarly, also certain variants (1, 113, 135, and 53) of inner membrane 
transporter gene cmeB were strongly associated with quinolone resistance, indicating that 
these variants will result in the efflux pumps with higher activity. 
 
The results of resistance spreading analysis of isolates from two different geographical areas 
both demonstrate the clonal expansion of the quinolone resistance among Campylobacter. 
Since the clonal spreading was observed with different clonal complexes, which are 
associated with more than one gyrA variant, the further research needs to be done in order to 
identify the key factors enabling the rapid spread of those resistant clones. 
 
3.1.4  Anti-Campylobacter, resistance modulatory and efflux inhibitory activity of A. 
katsumadai seeds formulations 
 
We have demonstrated in a previous study, that antibiotic resistance of C. jejuni clearly 
represents an alarming issue, especially, because it is the most prevalent foodborne bacterial 
cause of gastroenteritis in EU (EFSA, 2014a; Kovač et al., 2014a). For this reason, it is 
important to invest in the research of novel antimicrobials, also from plants, which represent 
an incredibly diverse source of bioactive chemicals. In our two studies we have investigated 
the anti-Campylobacter and resistance modulatory potential of Alpinia katsumadai seeds in 
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form of extracts, essential oil and post-distillation residue extract, which is usually disposed 
and represents an ecological burden (Kovač et al., 2014b). Plant formulations were tested 
against antibiotic resistant and antibiotic susceptible strains of C. jejuni and C. coli 
(Klančnik et al., 2012a; Kovač et al., 2014b). Additionally, their resistance modulatory and 
efflux inhibitory activity was investigated.  
 
We have found that ethanol extract of A. katsumadai seeds has a moderate antimicrobial 
activity (125 – 2051 mg/L) and at the same time the best antimicrobial activity, compared to 
the post-distillation residue extract and the essential oil. The inhibitory effect of the latter 
was the weakest. There was no difference in antimicrobial potential of extracts prepared 
using ethanol, methanol, dichloromethane and hexane on the reference C. jejuni strain. Also, 
C. coli strains were more resistant to ethanol extract than C. jejuni strains (Klančnik et al., 
2012a; Kovač et al., 2014b). This suggests that the seeds contain antimicrobial compounds 
of a wide polarity range. 
 
All three plant formulations (extract, essential oil and the residue extract) were then further 
investigated for their resistance modulatory activity in quarter (0.25 MIC) or half  (0.5 MIC) 
of their minimal inhibitory concentration in combination with two antibiotics (ciprofloxacin, 
erythromycin), disinfectant triclosan and common efflux pump substrate ethidium bromide 
(EtBr). The ethanol extract in a concentration of 0.25 MIC was confirmed as a 
Campylobacter resistance modulator in the first study, where modulation factors (MFs) of 
up to 64 were confirmed, but the activity was strain-specific (Klančnik et al., 2012a). When 
testing the post-distillation extract and essential oil as modulators at 0.5 MIC on C. jejuni, 
we found that the mean MF was 34 and 78, respectively, considering combinations with all 
antimicrobials. Overall the best resistance modulatory effects were observed in case of 
essential oil (Kovač et al., 2014b). For this reason we have further tested it in an EtBr 
accumulation assay, which is a good indicator of efflux inhibitory activity. Essential oil was 
able to significantly increase the accumulation of ethidium bromide in the reference C. 
jejuni strain. The accumulation achieved with A. katsumadai essential oil was even better 
than that with reference efflux pump inhibitor verapamil (Kovač et al., 2014b). To our 
knowledge, this is the first study of efflux inhibitory activity of plant extracts in C. jejuni. 
The demonstrated activity was exceptionally good, but the concentrations used (500 mg/L) 
were most likely too high to rationale its applicative use. Therefore we proceeded with 
screening of the resistance modulatory activity of the main chemical constituents of A. 
katsumadai seed essential oil. 
 
3.1.5  Anti-Campylobacter, resistance modulatory and efflux inhibitory activity of (-)-
α-pinene  
 
Alpha-pinene was confirmed as one of the chemical constituents of A. katsumadai seed 
essential oil, where it represented 2.18% of total essential oil content (Šikić Pogačar et al., 
2015, unpublished work). It was one of the candidate compounds that were likely 
responsible for antimicrobial and resistance modulatory activity of A. katsumadai seed 
essential oil presented in our previous studies (Klančnik et al., 2012a; Kovač et al., 2014b). 
It was further tested alone. Because (-)-α-pinene showed better results in preliminary 
experiments, this enantiomer was tested in further experiments to evaluate its antimicrobial, 
resistance modulatory and efflux inhibitory activity. 
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High MICs confirmed insignificant antimicrobial activity of (-)-α-pinene, but it had a high 
resistance modulatory potential. (-)-α-pinene was tested as a resistance modulator in 
concentrations 62.5 mg/L and 125 mg/L and it decreased the MICs of the tested 
antimicrobials by up to 2-fold in lower concentration and from 32 to over 256-fold in higher 
concentration, which was similar to observed for the essential oil. We have observed when 
evaluating the impact of (-)-α-pinene on the C. jejuni membrane integrity, the higher 
concentration was able to increase the membrane permeability, which was probably the 
cause of the better resistance modulatory effect.  
Both concentrations of (-)-α-pinene were tested in EtBr accumulation assay to evaluate their 
efflux inhibitory potential and were equally good in increasing the intracellular EtBr 
accumulation, therefore all further tests were carried out using the lower concentration, 
which did not impair the membrane integrity, in order to assess the sole efflux inhibitory 
impact. It was later found that the same level of activity is remained also when the 
concentration of the compound is decreased to 8 mg/L. Since we were especially interested 
in the target of our tested compound, we have tested it also on the mutants with disrupted 
open reading frames (ORFs) of the Campylobacter spp. main efflux system CmeABC and 
the yet uncharacterized efflux protein Cj1687. In both cases the increase in the EtBr 
accumulation was significantly lower compared to the wild type, which confirmed these two 
efflux systems as the targets of (-)-α-pinen. We have therefore confirmed (-)-α-pinene as an 
efflux inhibitor in C. jejuni with potential to be used in medicine, especially because 
cytotoxicity of α-pinene was already investigated on HeLa and Cos7 cell lines, where IC50 
concentrations of 357.9 and 337.5 mg/L were determined (Herrmann and Wink, 2011). 
These are 2 to 5-fold higher than those used in our study. 
 
In a recent study, similarly active Mycobacterium smegmatis potential efflux pump 
inhibitors from A. katsumadai seed extracts were identified (Gröblacher et al., 2012a). The 
activity of those was expressed at concentrations 32 to 64 mg/L and was equal or more 
pronounced than that of CCCP, but lower than that of verapamil. The active compounds 
were identified as (5R)-trans-1,7-diphenyl-5-hydroxyhept-6-en-3-one, (3S,5S)-trans-1,7-
diphenylhept-1-ene-3,5-diol and the flavanone pinocembrin (dihydrochrysin). Several 
putative inhibitors of M. smegmatis efflux pump were confirmed also in extracts of 
Aframomum melegueta (Gröblacher et al., 2012b). These were active in concentrations 16 to 
64 mg/L. Another novel natural product isolated from Hypericum olympicum L. cf. 
uniflorum was recently confirmed to have efflux inhibitory activity also in Staphylococcus 
aureus (Shiu et al., 2013). However, these have not identified the inhibited efflux systems. (-
)-α-pinene is the first confirmed Campylobacter spp. efflux pump inhibitor from plant 
sources. 
 
3.1.6  Adaptation of Campylobacter jejuni to treatment with (-)-α-pinene  
 
The bacterial response to stress caused by sub-inhibitory concentrations of phytochemicals 
is not yet well researched and the bacterial adaptation mechanisms are not fully understood. 
In our study we have investigated the C. jejuni response to treatment with sub-inhibitory 
concentration of efflux pump inhibitor (-)-α-pinen, in order to elucidate its mechanism of 
action and adaptation mechanism. 
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After 2-hour treatment of the reference strain with 62.5 mg/L of (-)-α-pinene, 129 genes 
were differently expressed, with cut-off set at ≥2-fold difference. Of those, 109 were up-
regulated and 20 down-regulated. The most strongly up-regulated (over 10-fold) were 
chaperone encoding genes grpE, dnaK, clpB and the heat-shock regulator hrcA. Another two 
heat shock response genes encoding chaperonin groES, cbpA and transcriptional repressor 
hspR were also up-regulated, but at lower levels (2 - 4-fold). Besides heat shock-response 
genes, also efflux pump genes cmeABC were 2.7 to 2.2-fold up-regulated, respectively. 
Another putative efflux protein gene Cj1687, which has not yet been characterized in C. 
jejuni was 2.5-fold up-regulated. These results were the first indication of (-)-α-pinene 
targeting these efflux systems and has lead us to look deeper into it.  
 
The expressional changes caused by treatment with (-)-α-pinene were strikingly similar to 
those previously observed in a mutant with defected transcriptional regulator hspR, i.e. 
highly up-regulated heat shock related genes grpE, dnaK, clpB and hrcA (Holmes et al., 
2010). The simple heat shock response model from the same study suggests repression of 
groES and groEL by hrcA and repression of dnaK, cbpA and clpB operon by hspR, which 
become de-repressed in the event of heat shock and consequently hrcA is up-regulated. 
According to our results the same transcriptional avalanche seems to occur after treatment 
with (-)-α-pinene, suggesting that heat shock response plays an important role in bacterial 
defence and adaptation to this chemical stress. Similar response was observed also after 
treatment of C. jejuni with natural antimicrobial compound benzyl isothiocyanate (Dufour et 
al., 2013). 
 
When the growth of mutants with disrupted ORFs hspR, hrcA and the wild type were 
examined in presence and absence of (-)-α-pinene, the wild type was able to grow best at 
given conditions, followed by hrcA, and hspR, respectively. The same or reduced growth of 
ΔhspR at normal growth temperatures was previously observed, while growth at high 
temperatures was increased (Holmes et al., 2010; Szintzi et al., 2005). Furthermore, the 
exposure to higher concentration of (-)-α-pinene had more pronounced negative effect on 
bacterial growth, compared to the wild type. The trend of decreasing growth in presence of 
(-)-α-pinene was observed in both, ΔhrcA and ΔhspR, indicating that these heat shock 
transcriptional repressors play an important role in adaptive response to treatment with (-)-α-
pinene. 
 
Furthermore, mutants in genes hspR, hrcA and wild type C. jejuni NCTC 11168 were grown 
on Biolog phenotype MicroArrays with different carbon sources and in presence of different 
osmolytes and pH, in order to elucidate their role in adaptation to this type of stresses. 
Growth of mutants was compared to the growth of wild type strain. The ΔhspR was growing 
better on some of the osmolytes, like 6% NaCl with KCl, sodium sulfate, sodium formate, 
sodium lactate and sodium phosphate, while growth of hrcA mutant, on the other hand, was 
inhibited by these and several other osmolytes. The hrcA was also not able to utilize a wide 
range of carbon sources as efficiently as the wild type. Besides ΔhspR showing increased 
ability to adapt to high concentrations of selected osmolytes, it was also previously 
confirmed to tolerate heat shock better than wild type, while the opposite was observed for 
ΔhrcA (Holmes et al., 2010). A former study of Cameron et al. (2012) showed that several 
heat shock related genes are up-regulated after osmotic shock and demonstrated that pre-
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treatment of C. jejuni with osmolytes will provide protection against oxidative stress, but not 
to heat shock stress. 
 
We concluded that the heat shock related genes importantly contribute to C. jejuni 
adaptation to several different stresses, like osmotic and chemical stress, including stress of 
(-)-α-pinene treatment. However, the mechanism itself is not yet fully understood, especially 
due to complex posttranslational regulation of heat shock transcriptional repressors HspR 
and HrcA. 
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3.2  CONCLUSIONS 
 
In our study we have approached the problematic of campylobacteriosis and antibiotic 
resistance in C. jejuni in a holistic way, investigating the underreporting of the disease, the 
prevalence and spreading of the antibiotic resistance in the pathogen, as well as finding new 
solutions to solving the increasing antibiotic resistance problematic by identifying novel 
antimicrobial, resistance and efflux modulatory natural products. Furthermore the targets of 
their action and adaptation response of bacteria were investigated to give a clearer picture of 
their mode of action. 
 
We have employed mathematical modelling using the Bayesian approach and linear 
regression to model the parameters influencing the underreporting and underdiagnosis 
(Haagsma et al., 2012). The underdiagnosis is the main reason for prevalence 
underestimation and the most significant contributions to the underdiagnosis arise, due to the 
low probability of a patient experiencing diarrhoea to visit a GP. The estimations based on 
our model show that for every case of reported campylobacteriosis in Slovenia there are 181 
unreported cases. Most of the underreporting occurs due to the underdiagnosis of non-
bloody diarrhoeal cases. 
 
We have confirmed the reports of high ciprofloxacin resistance, especially among poultry 
meat and faeces isolates. The resistance is more commonly observed in isolates with 
genotypes belonging to MLST clonal complex 21. Additionally, we have employed the gyrA 
QRDR typing and confirmed the clonal spreading of ciprofloxacin resistant strains based on 
the MLST clonality and genetic similarity of QRDR (Kovač et al., 2014a). Clonal expansion 
of quinolone resistance was additionally confirmed among the larger number of C. jejuni 
and C. coli strains from Oxfordshire, UK, based on their whole genome sequences. There 
however, the clonal complexes ST-354 and ST-464 were the ones with the highest 
proportions of quinolone resistant clones. 
 
We investigated the antimicrobial, resistance modulatory and efflux inhibitory potential of a 
Zingiberaceae, Alpinia katsumadai, used in traditional Chinese medicine. Its extracts from 
seeds, post-distillation residue extract, and essential oil had moderate to weak antimicrobial 
activity and essential oil was found to have high resistance modulatory and efflux inhibitory 
potential in C. jejuni (Klančnik et al, 2012a; Kovač et al, 2014b). Furthermore, the pure 
terpene compound α-pinene was found as one of the constituents of this essential oil and one 
of its enantiomers, (-)-α-pinene, was confirmed as a strong modulator of C. jejuni resistance 
against ciprofloxacin, erythromycin, triclosan and ethidium bromide. It has an efflux 
inhibitory activity that is significantly better than that of the reference efflux inhibitors 
CCCP and reserpine. The efflux systems CmeABC and Cj1687 were identified as the main 
targets of its efflux inhibitory activity.  
 
C. jejuni responded to treatment with (-)-α-pinene using the same regulatory set of genes as 
in heat shock response. This mechanism of adaptation was found also in response to other 
types of stresses, like osmotic stress and seems to be a type of general stress response system 
that protects bacteria from protein coagulation and thereby preventing the fatal 
consequences. 
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4  SUMMARY  
 
4.1  SUMMARY  
 
Campylobacteriosis is the most prevalent bacterial foodborne disease in EU and its 
incidence is thought to be significantly underreported, due to the self-limiting nature of the 
disease, which sometimes is expressed with only mild symptoms (EFSA, 2014a). Even so, 
the disease poses a tremendous economical and healthcare burden; therefore there have been 
many attempts of the estimation of its real prevalence. Over the time, many approaches to 
accomplishing that have been presented, but the most frequently used is the evaluating vital 
fractions that influence the underdiagnosis and underreporting of the disease. The 
prevalence is underestimated due to underreporting and under-diagnosis associated with 
passive surveillance, incorrect diagnosis and inefficient communication with authorities, as 
well as with the unregistered cases with mild symptoms that do not seek medical help 
(Haagsma et al., 2012).  
 
All the factors, which we believe are influencing the reporting prevalence, can be 
systematically updated given the data from successive finite samples using the Bayes’ 
theorem, which rationally changes a subjective belief by taking evidence into account. In 
order to build a Bayesian probabilistic graphical model, it is necessary to define the model 
parameters affecting the prevalence reporting, which are then systematically incorporated in 
the model. Because different parameters affecting the process of reporting are involved in 
cases of hospitalization, these are incorporated in a separate branch of the model. Also the 
differences in symptoms and severity of the disease caused by different pathogens, as well 
as the differences in medical and reporting practice among EU countries are considered, as 
well as the fact that some of the parameters depend on the country and others depend on the 
pathogen (Scallan et al., 2006; Scallan et al., 2011; Haagsma et al., 2012).  
 
In our study parameters were modelled using linear regression based on existing data for 
seven foodborne pathogens in seven EU countries. Only common statistical data available 
for EU countries was used to model the parameter uncertainty distributions. The Monte 
Carlo simulations of modelled parameters were used to estimate foodborne pathogen 
prevalence in additional EU countries. According to the model, the prevalence of 
campylobacteriosis in Slovenia needs to be corrected for the multiplier 181.  
 
Furthermore, the sensitivity of the model was investigated and the analysis revealed that in 
the EU countries the crucial factor, contributing the most to the underreporting is the 
probability of visiting the GP when experiencing the non-bloody diarrhoea. This can be 
explained with the fact, that the disease is of self-limiting nature and the patients, who 
experience only mild symptoms do not tend to seek medical help.  
 
Since the real prevalence of the disease is significantly higher than reported, it is important 
to understand how the pathogen spreads to human, in order to limit the disease rate. 
Nowadays the poultry meat is identified as the main source of sporadic campylobacteriosis 
infections, although most of the outbreaks are caused by consumption of contaminated water 
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or milk. Campylobacter spp. are bacteria that naturally cycles from environment to livestock 
and finally via meat to human, but the role of the environmental isolates in this chain is not 
fully understood.  
 
In our study we have investigated the transmittance of Campylobacter jejuni from 
environment along the food production chain to humans by employing the multi locus 
sequence typing (MLST) and flaA as the molecular tracing tools. MLST is a convenient 
typing method which enables to detect the long-term evolutionary genetic changes by 
examining the sequence variation of multiple loci of conserved housekeeping genes. It is 
portable, unambiguous and the results can be deposited in the international publicly 
available PubMLST database. FlaA typing was included to additionally increase the 
discriminatory power. Using MLST we have investigated the clonal structure of the selected 
C. jejuni population, comprising isolates from environmental waters, farm animals, poultry 
meat and human clinical cases. Forty-eight C. jejuni isolates out of total of 52 were assigned 
to ten pre-defined CCs and 28 STs by MLST. Clonal complexes 21 and 45 predominated 
and sequence types (ST) 50 and 104 were the most frequent sequence types. Twenty-three 
STs appeared only once, indicating high genetic diversity within a relatively small group of 
strain (Kovač et al., 2014a).  
 
The distribution of isolates in the MST analysis indicates some correlation between specific 
genotypes and their main source of isolation. The majority of human isolates (71%) were 
distributed in CC 21 and CC 353 and most of the meat isolates (67%) in CC 21 and CC 45, 
while animal isolates were mostly (67%) assigned to CC 21 and CC 354. Sequence types 
belonging to clonal complexes 21 and 45 were previously shown to be predominant in 
Europe and typical for poultry. In our case, 12 of 19  isolates assigned to CC 21 and six of 
eight assigned to the CC 45 were isolated from poultry meat or faeces. Water isolates were 
genetically the most diverse group and two out of five could not be assigned to any existing 
clonal complex. Their distinct sequence types present an interesting group with little in 
common with isolates from human and animal sources (Kovač et al., 2014a).  
 
Besides understanding the pathogen’s epidemiological characteristics, it is of great 
importance to elucidate also the trends of its antibiotic resistance spreading. Employing the 
molecular tools has allowed the correlation of specific genotypes with specific antimicrobial 
resistance profiles and shown that resistance to quinolones and macrolides are mostly 
associated with point mutations in gyrA and 23S rRNA, respectively, acting together with 
efflux mechanisms. The RND type efflux pumps of some Gram negative bacteria are able to 
extrude different types of antibiotics and can also be induced by their substrates (Mohamoud 
et al., 2007).  This indicates that environmental selective pressures play an important role in 
acquiring nonspecific, via active efflux, or specific, via point mutation, resistance against 
antimicrobial drugs. Specific STs have already been associated with quinolone resistance in 
strains with point mutations, but it is not yet known whether this is because these genotypes 
are more prone to the mutations conferring resistance or because they are clonal (Wirz et al, 
2010; Kittl et al., 2013; Wimalarathna et al., 2013). In our  study we have determined the 
antibiotic resistance, MLST and analysed the genetic similarity of ciprofloxacin resistant 
strains based on the quinolone resistance determining region (QRDR) within the gyrase gene 
gyrA in order to elucidate the characteristics of quinolone resistance expansion in C. jejuni 
(Kovač et al., 2014a). 
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Antibiotic resistance in C. jejuni is becoming a significant issue, not only in Slovenia, but 
also in other European countries with the most problematic being resistance against 
quinolones, which are the second group of drugs of choice for campylobacteriosis treatment. 
In Slovenia quinolones are widely used for the nonspecific treatment of bacterial 
gastroenteritis as well as for enterococcal and E. coli infections in poultry flocks. The 
prevalence of ciprofloxacin resistant animal Campylobacter isolates in Europe is reported to 
range from 37% to 84%, depending on the country which is consistent with our study where 
72% of animal and 44% of meat isolates were ciprofloxacin resistant and this increased to 
80% for human isolates. Almost all (94%) of ciprofloxacin resistant strains from our study 
were cross-resistant to nalidixic acid (EFSA, 2014; IVZ, 2014).  
 
Analysis of antibiotic resistance and MLST genotypes revealed that all but one of the 19 
strains of C. jejuni belonging to the predominant MLST clonal complex (CC) 21 were 
quinolone resistant. In order to determine whether the association of quinolone resistance 
with CC 21 was due to individual mutational events or an increased ability to spread 
clonally, we investigated the most common ciprofloxacin resistance conferring mutation 
Thr-86-to-Ile and analysed the QRDR by sequence typing. The results show that all 
phenotypically ciprofloxacin resistant isolates, with the exception of strain 180/08, have the 
mutation ACA to ATA in the 86th codon. Six additional silent mutations in the QRDR, were 
identified, which clearly indicate the high degree of genetic relatedness of ciprofloxacin 
resistant isolates from CC 21, which together with one strain from CC 658 and two strains 
with unassigned CCs form a separate group, when compared to ciprofloxacin resistant 
strains from all other clonal complexes. As quinolone resistance is quickly developed under 
antibiotic selective pressure and can persist long after cessation of treatment, we conclude 
that the high incidence of such strains within CC 21 found in our study is not due to high 
genetic plasticity of this particular clonal complex, but rather due to acquired efficiency of 
clonal spreading (Kovač et al., 2014a).  
 
The clonal expansion of quinolone resistance was further investigated by analysis of the 
whole genome sequences of 1711 C. jejuni and C. coli clinical strains isolated in 
Oxfordshire, UK, between June 2011 and June 2013. The prevalence of quinolone resistance 
was determined by assigning the resistance to isolates with resistance-conferring mutations 
in the gyrA gene. It was found that the quinolone resistance was the highest within the ST 50 
of clonal complex ST-21 (66.7% in year 1 and 51.7% in year 2), within the CC ST-354 
(83.3% in year 1 and 96.7% in year 2) and CC ST-464 (94.4%in year 1 and 88% in year 2). 
In order to explore the nature of the resistance expansion, we have built the core-genome 
phylogenies of isolates from clonal complexes ST-21, ST-354, and ST-464 and investigated 
the clustering of gyrA variants within the inferred phylogenetic networks. The distribution of 
gyrA allele variant 20, which was the main allele type associated with resistance in clonal 
complex ST-21, was observed in different clusters within the clonal complex, suggesting 
that it is not expanding clonally. On the other hand, the same gyrA variant clearly clustered 
within a major resistant group of isolates within the CC ST-354. Similarly, we observed the 
clustering of the isolates carrying the quinolone resistant gyrA allele 57 within a single 
group of CC ST-464, clearly indicating the clonal expansion of quinolone resistance with 
these two clonal complexes. 
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The increase in the rate of the resistance-conferring mutations within the gyrA gene was 
previously associated with the presence of the mfd (mutation frequency decline) gene (Han 
et al., 2008), which has lead us to investigate how the variability within the mfd might 
influence the quinolone resistance. We found that the alleles 106, 39, 19, 31 and 111 were 
associated with quinolone resistance, and that certain gyrA variants are significantly 
associated with certain mfd variants, suggesting that these two genes are not evolved 
independently. Similarly, also certain variants (1, 113, 135, and 53) of inner membrane 
transporter gene cmeB were strongly associated with quinolone resistance, indicating that 
these variants will result in the efflux pumps with higher activity. 
 
The results of resistance spreading analysis of isolates from two different geographical areas 
both demonstrate the clonal expansion of the quinolone resistance among Campylobacter. 
Since the clonal spreading was observed with different clonal complexes, which are 
associated with more than one gyrA variant, the further research needs to be done in order to 
identify the key factors enabling the rapid spread of those resistant clones. 
 
Increasing antibiotic resistance clearly presents a serious problem, since clinically used 
antibiotics are becoming less or completely inefficient in campylobacteriosis treatment.  
Search for alternative antimicrobials derived from plants seems to be a viable solution for 
mitigation of resistance. Plant extracts rich in phenolic compounds (phenolic extracts), and 
essential oils have long been shown to possess antimicrobial activity and were frequently 
studied and reviewed (Cowan, 1999; Burt, 2004; Klančnik et al., 2012c; Negi, 2012). They 
are especially interesting as they are generally recognized as safe and have potential to be 
used as preservatives in food products. Alpinia katsumadai Hayata (Zingiberaceae) is widely 
used in traditional Chinese medicine as an anti-emetic remedy and to increase the appetite, 
but also in animal feed, to facilitate rapid growth of domestic animals. In our study we have 
focused on investigating bioactivity of the A. katsumadai extracts, essential oil and also the 
extract from the post-distillation material, which remains as a waste product after essential 
oil production. Such residual materials are often disposed of and may present an 
environmental problem. Their high phenolic content and the potential to provide an 
economically feasible source of natural antioxidants and antimicrobials is unused.   
 
Initially A. katsumadai seeds, extracted with different solvents were tested for antimicrobial 
activity against the reference C. jejuni strain and there was no difference in the antimicrobial 
activity (MIC=512 mg/L). Further, ethanol extract, essential oil and the post-distillation 
extract of A. katsumadai seeds were tested for their antimicrobial activity against several C. 
jejuni and/or C. coli isolates. Among each bacterial species tested, antibiotic sensitive and 
resistant strains, including multidrug resistant ones, were included. Statistically significant 
differences between the antimicrobial activities of different plant formulations were 
observed. According to the average MICs of each formulation, A. katsumadai ethanol 
extract from seeds was the most efficient antimicrobial plant formulation, with MICs 
ranging from 125 to 2051 mg/L, followed by its post-distillation extract. We could not 
confirm any difference between antimicrobial activities of tested plant formulations against 
antibiotic sensitive or resistant strains; they were active also against multidrug resistant 
strains. As observed from our results, the antimicrobial activity of tested plant formulations 
is species- and strain-specific. According to the MICs, which are consistently higher than 
100 mg/L, we can conclude, that they have weak to moderate antimicrobial activity in 
Campylobacter (Klančnik et al, 2012a; Kovač et al., 2014b). 
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In addition to searching for new antimicrobially active plant formulations, the antibiotic 
resistance combating strategies are focused also on resistance modulators. These are not 
necessarily antimicrobially active, but can decrease the resistance of pathogens when 
administered together with other antimicrobials. The microbial sensitization by resistance 
modulators is mostly due to efflux inhibition, increased membrane permeability, and 
increased porin production or change in porin profile (Bolla et al., 2011). 
 
Beside direct antimicrobial activity, we tested and confirmed also remarkable resistance-
modulatory activity of A. katsumadai extract, essential oil and post-distillation extract in C. 
jejuni. A. katsumadai seed ethanol extract was confirmed for the first time to modulate 
antibiotic resistance in Campylobacter in our first study, where it was demonstrated to 
decrease the MICs of tested antimicrobials ciprofloxacin, erythromycin, ethidium bromide, 
bile salts, sodium deoxycholate, rosemary extract and epigalocatechin gallate for up to 16-
fold. In the second study we comparatively investigated the resistance-modulatory potential 
of additional A. katsumadai essential oil and post-distillation extract. They were tested as 
modulators in concentrations half of their MIC on each individual strain of C. jejuni and in 
combination with antimicrobials ciprofloxacin, erythromycin, triclosan, bile salts and 
ethidium bromide. When testing the post-distillation extract and essential oil as modulators, 
we found that the mean MF value was 34 and 78, respectively, considering combinations 
with all antimicrobials. The essential oil was therefore confirmed as the best modulator. The 
comparative analysis of modulatory activity of A. katsumadai formulations in 
Campylobacter confirmed them as equally efficient in combination with different 
antimicrobials, including bile salts (mean MF >55). This is important since the intestinal 
tract with the presence of bile salts is a natural environment and reservoir of Campylobacter, 
so resistance to bile salts is essential for Campylobacter survival and virulence potential 
(Klančnik et al., 2012a; Kovač et al., 2014b).  
 
There are several possible mechanisms of increasing susceptibility of bacteria to antibiotics 
and other antimicrobials. The most promising are focusing on increasing the antibiotic influx 
by destabilizing LPS in Gram negative bacteria and increasing the membrane permeability 
and blocking the efflux using efflux pump inhibitors (Bolla et al., 2011). In order to 
elucidate the mechanism of modulatory activity of A. katsumadai essential oil in C. jejuni, 
we have evaluated its potential to increase the accumulation of the common efflux pump 
substrate ethidium bromide, which is an indicator of the efflux inhibition. The extract and 
post-distillation extract were excluded from the experiments because of the high auto 
fluorescence. We have compared the levels of EtBr accumulation in cultures treated with 0.5 
and 0.25 MIC of essential oil, relative to untreated culture, to evaluate whether it can 
potentiate the intracellular EtBr accumulation. Known efflux pump inhibitor verapamil was 
included in the study as a positive reference (Kovač et al., 2014b).  
 
The results showed significant increase in EtBr accumulation in presence of A. katsumadai 
essential oil. The accumulation of EtBr was for 1.7-fold better in presence of 0.5 MIC of A. 
katsumadai essential oil than in the presence of positive control, verapamil. The mean 
accumulation values in presence of 0.25 MIC of essential oil were almost the same as in 
presence of 0.5 MIC, only the time needed to reach the maximum accumulation was 
different. The gradual decrease in EtBr accumulation after reaching the plateau might be due 
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to the facilitation of EtBr influx by essential oil and insufficient capacity to block the efflux 
(Kovač et al., 2014b).  
 
Because of the efficient resistance modulatory and efflux inhibitory activity of the A. 
katsumadai essential oil, we have aimed to identify the compounds responsible for this 
activity. We have analysed the chemical composition of the essential oil and identified 95% 
of the compounds present. The compounds present in amounts over 1% were (in descending 
order) 2Z,6E-farnesol, 1,8-cineole, α-humulene, cymene, α-phellandrene, carotol, 
caryophyllene, daucene, α-pinene, δ-cadinene, 2-butanone, 3-phenyl or 2-butanone, 4-
phenyl, α-terpineol and β-pinene. Our pre-screening has lead us to analyse more in depth the 
compound α-pinene, which was present in the essential oil in the amount of 2.2%. Due to 
the better activity in the initial tests, we have used the (-)-α-pinene in further investigations. 
 
The MICs of (-)-α-pinene were 1000 mg/L or higher in all tested strains of C. jejuni, 
including those tested in resistance modulation assay. High MICs confirmed insignificant 
antimicrobial activity of (-)-α-pinene. As a potential resistance modulator (-)-α-pinene was 
tested in concentrations 62.5 mg/L and 125 mg/L in combination with antibiotics 
ciprofloxacin and erythromycin, disinfectant triclosan and efflux pump substrate EtBr on a 
reference strain C. jejuni NCTC 11168. In concentration 62.5 mg/L it decreased the MICs of 
these antimicrobials by up to 2-fold and in concentration 125 mg/L from 32 to over 256-
fold. Similarly, strong modulatory activity was observed also for seed essential oil. 
 
Before the EtBr accumulation assessment, both concentrations of (-)-α-pinene used in the 
resistance modulatory assay were tested for their influence on the C. jejuni membrane 
integrity in order to refute the influence on increased membrane permeability as the main 
mechanism of resistance modulation. The membrane integrity of culture treated with 62.5 
mg/L was even by 20% higher relative to untreated culture after 1 h treatment, while higher 
concentration of 125 mg/L decreased the membrane integrity by 39%.  
 
Both concentrations of (-)-α-pinene were tested for their ability to increase the intracellular 
EtBr accumulation in reference C. jejuni strain. The use of lower concentration of 62.5 mg/L 
resulted in higher EtBr accumulation. At the same time this concentration did not have 
negative impact on membrane integrity and was therefore used in further screening of a 
larger set of isolates. This enabled us to investigate solely its efflux inhibitory effects. We 
observed relative increase in EtBr accumulation when (-)-α-pinene was added in all 16 
tested strains. The (-)-α-pinene was able to increase EtBr accumulation significantly better 
compared to CCCP and reserpine in all tested strains, confirming its remarkable efflux 
inhibitory activity. It maintained the same level of activity also in concentration 8 mg/L. 
This suggests that it could be the compound responsible for efflux inhibition in A. 
katsumadai seed essential oil, although the share of (-)-α-pinene in the α-pinene present in 
the essential oil was not determined. However, the contribution of other constituents to the 
overall efflux inhibitory activity of the essential oil cannot be excluded. 
 
To determine the target efflux system of (-)-α-pinene, we have compared the EtBr 
accumulation in wild type and in mutants with interrupted open reading frames of efflux 
pump genes ΔcmeB and ΔCj168. The accumulation of EtBr in the mutants was significantly 
lower, indicating the absence of (-)-α-pinene target in these two mutants. From these results 
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we conclude, that efflux systems CmeABC and Cj1687 are the targets of (-)-α-Pinene efflux 
inhibitory activity. 
 
In order to decipher the bacterial adaptive response to treatment with sub-inhibitory 
concentrations of (-)-α-pinene used in the EtBr accumulation assay, we have carried out the 
whole genome expressional analysis using microarray technology and qPCR. After 2-hour 
treatment with 62.5 mg/L of (-)-α-pinene, 129 genes of C. jejuni NCTC 11168 were 
differently expressed, with cut-off set at ≥2-fold difference. Of those, 109 were up-regulated 
and 20 down-regulated. The most strongly up-regulated (over 10-fold) were chaperone 
encoding genes grpE, dnaK, clpB and the heat-shock regulator hrcA. Another two heat 
shock response genes encoding chaperonin groES, cbpA and transcriptional repressor hspR 
were also up-regulated, but at lower levels (2- 4-fold). Besides heat shock-response genes, 
also efflux pump genes cmeABC were 2.7 to 2.2-fold up-regulated, respectively. Another 
putative efflux protein gene Cj1687, which has not yet been characterized in C. jejuni was 
2.5-fold up-regulated. 
 
The expressional changes caused by treatment with (-)-α-pinene were strikingly similar to 
those previously observed in a mutant with defected transcriptional regulator hspR. That is 
highly upregulated heat shock related genes grpE, dnaK, clpB and hrcA. The simple heat 
shock response model from the same study suggests repression of groES and groEL by hrcA 
and repression of dnaK, cbpA and clpB operon by hspR, which become derepressed in the 
event of heat shock and consequently hrcA is upregulated. According to our results the same 
transcriptional avalanche seems to occur after treatment with (-)-α-pinene, suggesting that 
heat shock response plays an important role in bacterial defense and adaptation to this 
chemical stress. Similar response was observed in another study also after treatment of C. 
jejuni with natural antimicrobial compound benzyl isothiocyanate. 
 
To confirm the role of these genes in the adaptive response, we have constructed the mutants 
in genes hspR and hrcA and use them in the phenotypical tests. The growth of mutants with 
disrupted ORFs hspR, hrcA and the wild type NCTC 11168 was examined in presence and 
absence of (-)-α-pinene. The wild type NCTC 11168 was able to grow best at given 
conditions, followed by hrcA, and hspR, respectively. Furthermore, the exposure to higher 
concentration of (-)-α-pinene had more pronounced negative effect on bacterial growth, 
compared to the untreated cultures. The trend of decreasing growth in presence of (-)-α-
pinene was observed in both, ΔhrcA and ΔhspR, indicating that these heat shock 
transcriptional repressors play and important role in adaptive response to treatment with (-)-
α-pinene. 
 
Furthermore, mutants in genes hspR, hrcA and wild type C. jejuni NCTC 11168 were grown 
on Biolog phenotype MicroArrays with different carbon sources and in presence of different 
osmolytes and pH, in order to elucidate their role in adaptation to this type of stresses. 
Growth of mutants was compared to the growth of wild type strain. The hspR mutant was 
growing better on some of the osmolytes, like 6% NaCl with KCl, sodium sulphate, sodium 
formate, sodium lactate and sodium phosphate, while growth of hrcA mutant, on the other 
hand, was inhibited by these and several other osmolytes. The hrcA was also not able to 
utilize a wide range of carbon sources as efficiently as the wild type.  
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Based on these results we conclude that heat shock related genes importantly contribute to 
C. jejuni adaptation to several different stresses, like osmotic and chemical stress, including 
stress of (-)-α-pinene treatment. However, the mechanism itself is not yet fully understood, 
especially due to complex posttranslational regulation of heat shock transcriptional 
repressors HspR and HrcA. 
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4.2  POVZETEK  
 
Kampilobakterioza je v državah Evropske Unije najpogostejša bolezen povzročena z 
okužbami s hrano (EFSA, 2014a). Ker se bolezen pogosto kaže le z blagimi simptomi in se 
pozdravi tudi brez zdravljenja, se predvideva, da je dejanska prevalenca bolezni znatno višja 
od poročane. Ker kampilobakterioza predstavlja veliko ekonomsko in javnozdravstveno 
breme, je ocena realne prevalence bolezni cilj številnih raziskav. Skozi čas so bili 
predstavljeni različni pristopi k sistematičnemu ocenjevanju stopnje podcenjenosti 
poročanja, vendar se je najbolj uveljavil način ocenjevanja ključnih dejavnikov, ki 
prispevajo k podcenjevanju diagnoz in poročanja kampilobakterioz. Prevalenca bolezni je 
podcenjena zaradi nezadostnega poročanja in diagnosticiranja, ki je posledica pasivnega 
nadzora, nepravilnih diagnoz in neučinkovitega komuniciranja z oblastmi, kot tudi zaradi 
neregistriranih primerov z blagimi simptomi, ki se ne odločijo za posvetovanje z 
zdravnikom (Haagsma in sod., 2012).  
 
Vse dejavnike, za katere verjamemo, da vplivajo na nezadostno poročanje prevalence, lahko 
sistematično upoštevamo pri oceni realne prevalence s pomočjo Bayesovega teorema, ki 
racionalno preoblikuje subjektivna prepričanja s tem, da upošteva dokaze v obliki podatkov, 
pridobljenih iz zaporednih končnih vzorcev. Prvi korak k postavitvi Bayezijskega grafičnega 
verjetnostnega modela je definicija parametrov modela, za katere verjamemo, da vplivajo na 
nezadostno poročanje prevalence. Ti parametri so nato sistematično vgrajeni v model. Ker 
na poročanje prevalence hospitaliziranih primerov vplivajo drugačni parametri, kot na 
poročanje primerov, ki obiščejo samo osebnega zdravnika, so hospitalizirani primeri v 
model vključeni kot ločena veja. Naslednja razlika, ki jo je potrebno upoštevati pri grajenju 
modela, so razlike v simptomih in resnosti bolezni v primeru različnih patogenov, kot tudi 
razlike v medicinskih in poročevalnih navadah med posameznimi državami Evropske Unije. 
Tako so nekateri parametri odvisni od patogena, ki povzroča bolezen, spet drugi od države 
(Scallan in sod., 2006; Scallan in sod., 2011; Haagsma in sod., 2012). 
 
V naši študiji smo parametre modelirali s pomočjo linearne regresije na podlagi obstoječih 
podatkov za sedem patogenov, povezanih s hrano v sedmih državah Evropske Unije. Pri 
modeliranju parametrov smo uporabili samo splošne statistične podatke, dostopne na 
Eurostatu. S pomočjo Monte Carlo simulacij smo upoštevajoč strukturo Bayezijskega 
modela ocenili prevalence patogenov v dodatnih državah EU. Naša ocena kaže na znatno 
podcenjenost prevalence kampilobakterioz v Sloveniji, in sicer za faktor 181. 
 
Poleg ocene stopnje nezadostnega poročanja smo analizirali tudi občutljivost modela. 
Analize so pokazale, da je verjetnost bolnika za obisk zdravnika dejavnik, ki ključno 
prispeva k nezadostnemu poročanju. Še posebaj majhna je verjetnost za obisk zdravnika pri 
bolnikih z nekrvavo diarejo. To pojasni dejstvo, da je kampilobakterioza bolezen, ki se 
pogosto odraža v blagih simptomih in je samoomejujoča. Zaradi tega se veliko bolnikov ne 
odloči za iskanje medicinske pomoči in njihovi primeri ostanejo spregledani s strain oblasti. 
 
Ker je realna prevalenca znatno višja od poročane, je za njeno omejitev oz. znižanje nujno 
potrebno razumevanje širjenja patogena do človeka. Dandanes je perutninsko meso 
identificirano kot glavni vir sporadičnih okužb z bakterijami Campylobacter spp., čeprav je 
večina izbruhov povzročenih zaradi uživanja kontaminirane vode ali mleka. Campylobacter 
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spp. so bakterije, ki naravno krožijo iz okolja do proizvodnih živali in končno preko mesa do 
ljudi. Kljub temu ostaja vloga okoljskih sevov v tej verigi prenosa slabo pojasnjena. 
 
V našem delu smo raziskovali širjenje bakterij Campylobacter jejuni iz okoljskih virov 
preko živilsko predelovalne verige do ljudi. Pri tem smo uporabili multilokusno sekvenčno 
tipizacijo (MLST) in tipizacijo na podlagi gena flaA kot molekularni sledilni orodji. MLST 
je priročna tipizacijska metoda, ki omogoča detekcijo dolgoročnih evolucijskih genetskih 
sprememb. Osredotoča se na analizo sekvenčnih variacij v sedmih ohranjenih hišnih genih. 
Metoda je prenosljiva, nedvoumna in enostavna. Rezultati so zaradi tega primerljivi med 
laboratoriji, poleg tega pa se lahko uvozijo v javno dostopno podatkovno bazo PubMLST. 
Tipizacija na podlagi flaA je bila vključena z namenom povišanja diskriminatorne moči. S 
pomočjo metode MLST smo preučevali klonsko strukturo izbrane populacije C. jejuni, v 
katero smo vključili seve iz okoljskih voda, farmskih živali, piščančjega mesa in humanih 
kliničnih primerov. Oseminštiridest isolatov C. jejuni od skupno dvainpetdesetih je bilo z 
metodo MLST razporejenih v deset klonskih kompleksov (CC) in 28 sekvenčnih tipov (ST). 
Prevladovala sta klonska kompleksa 21 in 45 in sekvenčna tipa 50 in 104. Triindvajset 
sekvenčnih tipov se je pojavilo zgolj enkrat, kar nakazuje na izjemno visoko genetsko 
diverziteto znotraj relativno majhne skupine sevov (Kovač in sod., 2014a). 
 
Porazdelitev izolatov s pomočjo drevesa minimalnega razpona nakazuje na korelacijo 
specifičnih genotipov in njihovega vira izolacije. Večina humanih izolatov (71 %) je bila 
razporejena v CC 21 in CC 353, medtem ko je večina mesnih izolatov bila značilna za CC 
21 (67 %) in CC 45. Sedeminšestdeset odstotkov živalskih izolatov je imelo genotipe, 
značilne za CC 21 in CC 354. Sekvenčni tipi, ki pripadajo CC 21 in 45 so bili že v 
preteklosti prevladujoči v Evropi in so tipični za perutnino. V našem primeru je bilo 12 od 
19 izolatov razvrščenih v CC 21 in šest od osmih razvrščenih v CC 45, iz perutninskega 
mesa ali fecesa. Vodni izolati so se genetsko najbolj raziskovali od izolatov iz ostalih virov. 
Dva od petih izolatov nista bila dodeljena nobenemu klonskemu kompleksu. Njihovi različni 
sekvenčni tipi predstavljajo zanimivo skupino, ki ima malo skupnega z izolati iz živali in 
ljudi (Kovač in sod., 2014a). 
 
Klonsko širjenje kinolonske odpornosti smo naprej preučevali z analizo sekvenc celotnih 
genomov 1711 humanih kliničnih izolatov C. jejuni in C. coli, zbranih v Oxfordširu v 
obdobju med junijem 2011 in junijem 2013. Prevalenca kinolonske odpornosti je bila 
določena na podlagi odpornost-zagotavljajočih mutacij v genu gyrA. Odpornost proti 
kinolonom je bila najvišja v v klonskem kompleksu ST-464 (94,4 % in 88 % odpornih v 
prvem in drugem letu), v klonskem kompleksu ST-354 (83,3 % in 96,7 % odpornih v prvem 
in drugem letu), ter v sekvenčnem tipu ST 50 iz klonskega kompleksa ST-21 (66,7 % in 51,7 
% odpornih v prvem in drugem letu). Z namenom preučiti naravo širjenja kinolonske 
odpornosti smo na podlagi genomskih sekvenc zgradili filogenetske mreže izolatov iz 
klonskih kompleksov ST-21, ST-354 in ST-464 in preučili skupinjenje alelnih različic gena 
gyrA znotraj posameznih filogenetskih mrež. Porazdelitev alelne različice 20, ki je bila 
povezana z odpornostjo v sekvenčnem tipu 50 klonskega kompleksa ST-21, ni potrdila 
klonskega izvora. Nasprotno se je pa enaka različica gena gyrA v klonskem kompleksu ST-
354 jasno porazdelila znotraj glavne skupine odpornih izolatov. Podobno je bilo opaženo 
tudi za alelno različico 57 v klonskem kompleksu ST-464, kar jasno nakazuje na klonski 
način širjenja kinolonske odpornosti v teh dveh klonskih kompleksih. 
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Naraščanje stopnje nastajanja spontanih mutacij v genu gyrA, ki zagotavljajo odpornost proti 
kinolonom je povezana s prisotnostjo gena mfd (Han in sod., 2008), zato smo preučili kako 
je variabilnost v genu mfd povezana z odpornostjo proti kinolonom. Ugotovili smo, da so 
alelni tipi 106, 39, 31 in 111 povezani z odpornostjo in da so določene različice gena gyrA 
znatno povezane z določenimi različicami gena mfd, kar nakazuje na to, da se gena nista 
razvijala neodvisno eden od drugega. Podobno smo opazili, da so določene različice (1, 113, 
135 in 53) gena za notranji transmembranski transporter CmeB močno povezane s 
kinolonsko odpornostjo, kar nakazuje na to, da se te različice izrazijo v proteinih z večjo 
učinkovitostjo izčrpavanja kinolonskih antibiotikov. 
 
Poleg razumevanja patogenovih epidemioloških značilnosti je pomembno tudi poznavanje 
trendov širjenja antibiotske odpornosti med bakterijami C. jejuni. S pomočjo molekularnih 
orodij lahko raziskujemo povezave med specifičnimi genotipi in odpornostnimi profili in 
dokažemo, da je odpornost proti kinolonom in makrolidom povezana s točkovnimi 
mutacijami v genih gyrA in 23S rRNA. Odpornost lahko dodatno okrepi tudi ojačana 
aktivnost bakterijskih efluksnih sistemov.  
 
Efluksne črpalke tipa RND so v nekaterih Gram negativnih bakterijah sposobne izločanja 
različnih tipov antibiotikov. Njihova aktivnost je lahko inducirana z njihovimi lastnimi 
substrati, kar nakazuje na to, da igra selektivni pritisk pomembno vlogo pri pridobitvi 
nespecifične ali specifične odpornosti proti poritmikrobnim zdravilom (Mahamoud in sod., 
2007). Določeni sekvenčni tipi so že bili povezani z odpornostjo proti kinolonom v sevih z 
omenjenimi točkovnimi mutacijami, vendar do danes še ni bilo pojasnjeno, ali pride do tega 
zato, ker so ti genotipi bolj nagnjeni k nastanku individualnih mutacij ali gre za klonsko 
širjenje sevov s pridobljenimi mutacijami, ki zagotavljajo odpornost (Wirz in sod., 2010; 
Kittl in sod., 2013; Wimalarathna in sod., 2013). V našem delu smo določili antibiotsko 
odpornost, MLST genotipe in analizirali genetsko sorodnost sevov, odpornih proti 
ciprofloksacinu, na podlagi regije za zagotavljanje odpornosti proti kinolonom (QRDR) 
znotraj gena gyrA. Namen analize je bil pojasnitev značilnosti širjenja odpornosti bakterij C. 
jejuni proti antibiotikom iz skupine kinolonov (Kovač in sod., 2014a). 
 
Odpornost bakterij C. jejuni proti antibiotikom postaja problematično ne le v Sloveniji, 
temveč tudi v ostalih državah Evropske Unije. Izmed trenutno uporabljanih kliničnih 
antibiotikov, je nevarno visoka odpornost proti kinolonom. Ta skupina antibiotikov je, poleg 
makrolidov, prva izbira za zdravljenje kampilobakterioz, zato je njihova učinkovitost 
velikega pomena. V Sloveniji se kinoloni uporabljajo za zdravljenje nespecifičnih 
gastroenteritisov bakterijskega izvora, kot tudi za zdravljenje enterokoknih in okužb z E. 
coli pri perutnini. Prevalenca odpornosti proti ciprofloksacinu je med živalskimi izolati v EU 
od 37 % do 84 % (EFSA, 2014b), kar je v skladu z našimi opažanji, saj smo med  35 
mesnimi izolati zabeležili 77 % odpornih proti ciprofloksacinu. Skoraj vsi (94 %) proti 
ciprofloksacinu odporni sevi iz naše študije so bili navzkrižno odporni tudi proti 
nalidiksinski kislini (EFSA, 2014b; IVZ, 2014). 
 
Analiza antibiotske odpornosti in MLST genotipov je razkrila, da so vsi, razen enega izmed 
19 sevov C. jejuni, ki pripadajo klonskemu kompleksu 21, odporni proti kinolonom. V 
našem delu smo želeli ugotoviti ali povezava med CC 21 in odpornostjo proti 
ciprofloksacinu obstaja zaradi visoke stopnje individualno nastalih točkovnih mutacij v genu 
gyrA, ali zaradi povečane sposobnosti klonskega širjenja odpornih sevov. Tega smo se lotili 
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s preučevanjem najbolj značilne mutacije Thr-86-Ile in nukleotidnega zaporedja regije 
QRDR znotraj gena gyrA. Rezultati so pokazali, da so imeli vsi sevi, odporni proti 
ciprofloksacinu, z izjemo enega, mutacijo ACA v ATA v 86. kodonu. Dodatno so imeli šest 
tihih mutacij v regiji QRDR, kar jasno nakazuje na visoko stopnjo genetske sorodnosti 
sevov iz CC 21, odpornih proti ciprofloksacinu. Ker se kinolonska odpornosti hitro razvije 
pod selektivnim antibiotskim pritiskom in lahko še dolgo vztraja tudi v okolju brez 
selektivnega pritiska, sklepamo, da je visoka pojavnost takih sevov znotraj klonskega 
kompleksa 21 posledica pridobljene povečane učinkovitosti klonskega širjenja, in ne zaradi 
visoke genetske plastičnosti omenjenega klonskega kompleksa (Kovač in sod., 2014a). 
 
Naraščajoča odpornost proti antibiotikom nedvomno predstavlja resen problem, saj klinično 
uporabljani antibiotiki postajajo manj ali celo popolnoma neučinkoviti pri zdravljenju 
kampilobakterioz. Iskanje alternativnih protimikrobnih sredstev iz rastlinskih virov tako 
predstavlja dobro rešitev za premostitev bakterijske odpornosti. Rastlinski izvlečki, bogati s 
fenolnimi spojinami, in eterična olja so že dolgo znana po tem, da imajo protimikrobne 
lastnosti in so iz tega razloga pogosti preučevani (Cowan, 1999; Burt, 2004; Klančnik in 
sod., 2012c; Negi, 2012). Posebej zanimivi so zato, ker so splošno priznani kot varni in 
imajo potencial za uporabo v vlogi konzervansov v hrani. Alpinia katsumadai Hayata 
(Zingiberaceae) je splošno uporabljana rastlina v tradicionalni kitajski medicini, in sicer kot 
sredstvo proti želodčnim težavam in slabosti, kot tudi za dvig apetita. Uporablja se tudi kot 
krma za izboljšanje rasti domačih živali. V našem delu smo se osredotočili na preučevanje 
bioaktivnosti izvlečka semen A. katsumadai, kot tudi eteričnega olja in izvlečka odpadnega 
materiala po destialciji eteričnega olja. Tovrstni odpadni materiali so pogosto zavrženi in 
predstavljajo okoljski problem. Njihova visoka vsebnost fenolnih spojin in potencial za 
izrabo, kot ekonomičen vir naravnih oksidantov in protimikrobnih spojin, pa ostaja 
neizkoriščen (Klančnik in sod., 2012a; Kovač in sod., 2014b). 
 
Sprva smo izvlečke semen A. katsumadai, pripravljene z različnimi topili, testirali za 
protimikrobno aktivnost na referenčnem sevu C. jejuni. Ugotovili smo, da topilo ni 
pomembno vplivalo na protimikrobni potencial izvlečka, saj je bila pri vseh določena 
minimalna inhibitorna koncentracija 512 mg/l. Sledilo je testiranje etanolnega izvlečka 
semena, eteričnega olja in etanolnega izvlečka odpadnega materiala na številčnejši skupini 
izolatov C. jejuni in C. coli. Med sevi vsake vrste so bili vključeni tako občutljivi kot proti 
antibiotikom odporni sevi. Opažene so bile statistično značilne razlike v protimikrobni 
učinkovitosti testiranih rastlinskih pripravkov. Glede na minimalne inhibitorne koncentracije 
(MIK) je bil etanolni izvleček protimikrobno najučinkovitejši z MIK-i med 125 in 2051 
mg/l, nakar je sledil izvleček odpadnega materiala. Pri protimikrobni učinkovitosti 
rastlinskih pripravkov nismo ugotovili razlik v učinkovitosti delovanja na proti antibiotikom 
občutljive in odporne seve. Učinkoviti so bili tudi na mnogokratno odpornih sevih. 
Ugotovili smo, da je protimikrobna učinkovitost vrstno in sevno specifična. Glede na MIK-
e, ki so bili dosledno višji od 100 mg/L, sklepamo, da imajo zmerno do šibko protimikrobno 
učinkovitost na bakterijah Campylobacter (Klančnik in sod., 2012a; Kovač in sod., 2014b). 
 
Poleg iskanja novih protimikrobnih rastlinskih pripravkov se strategije boja proti odpornosti 
osredotočajo tudi na modulatorje odpornosti. Le-ti niso nujno protimikrobno učinkoviti, 
vendar lahko znižajo odpornost patogenih bakterij, ko se dodajajo skupaj z obstoječimi 
protimikrobnimi sredstvi in na ta način povečajo oziroma obnovijo njihovo učinkovitost. Do 
povečanja občutljivosti protimikrobnih sredstev pride v tem primeru večinoma zaradi 
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inhibicije efluksa, povečane prepustnosti membrane, povečane sinteze proteinov ali 
spremembe porinskega profila (Bolla in sod., 2011). 
 
V našem delu smo tako poleg protimikrobne učinkovitosti ugotavljali in potrdili tudi 
odpornostno mudulatorni potencial rastlinskih pripravkov iz semen A. katsumadai na 
bakterijah C. jejuni. Etanolni izvleček je bil potrjen kot modulator odpornosti v C. jejuni in 
C. coli v naši prvi študiji, kjer smo dokazali, da v subinhibitorni koncentraciji poveča 
učinkovitost ciprofloksacina, eritromicina, etidijevega bromida, žolčnih soli, rožmarinovega 
izvlečka in epigalokatehin galata za do 16-krat. V drugem delu smo primerjalno preučevali 
odpornostno modulatorno učinkovitost eteričnega olja in izvlečka odpadnega materiala. Kot 
modulatorja sta bila rastlinska pripravka testirana v polovični minimalni inhibitorni 
koncentraciji vsakega posameznega seva, in sicer v kombinaciji z antibiotikoma 
ciprofloksacinom, eritromicinom, razkužilom triklosan, žolčnimi solmi ter splošnim 
substratom efluksnih črpalk etidijevim bromidom. Eterično olje je v povprečju povečalo 
učinkovitost testiranih protimikrobnih sredstev za 78-krat, medtem ko je odpadni material 
povečal prtimikrobno učinkovitost testiranih spojin za 34-krat. Eterično oje je bilo potrjeno 
kot najučinkovitejši modulator odpornosti pri bakterijah C. jejuni. Vsi posamezni testirani 
rastlinski pripravki so bili enako učinkoviti v kombinaciji z vsemi testiranimi 
protimikrobnimi sredstvi, vključno z žolčnimi solmi. Slednje je pomembno, ker so žolčne 
soli naravno prisotne v gastrointestinalnem traktu, ki služi kot rezervoar bakterij 
Campylobacter. Odpornost proti žolčnim solem je torej nujna za preživetje in infektivnost 
bakterij v tem okolju (Klančnik in sod., 2012a; Kovač in sod, 2014b). 
 
Obstaja več različnih strategij za povečanje občutljivosti bakterij na antibiotike in ostala 
protimikrobna sredstva. Najbolj obetajoče se osredotočajo na povečanje vnosa antibiotikov v 
celico z destabilizacijo lipopolisaharidenga sloja Gram negativnih bakterij in povečanje 
membranske prepustnosti ter blokiranje efluksa z uporabo efluksnih inhibitorjev (Bolla in 
sod., 2011). Da bi ugotovili kakšen je mehanizem odpornostno modulatornega delovanja 
eteričnega olja iz semen A. katsumadai na baktetrijah C. jejuni, smo ocenili njegov potencial 
za povečanje znotrajcelične akumulacije etidijevega bromida. Povečanje akumulacije tega 
splošnega substrata efluksnih črpalk je namreč dober indikator za efluks inhibitorno 
učinkovitost. Etanolni izvleček in izvleček odpadnega materiala sta bila iz tehničnih 
rezlogov izključena iz analiz zaradi lastne avtofluorescence, ki je onemogočala meritve. V 
našem delu smo primerjali stopnje akumulacije etidijevega bromida v kulturah, tretiranih s 
subinhibitorno koncentracijo eteričnega olja (0,25 ali 0,5 MIK) in netretiranih kulturah, da bi 
ocenili ali eterično olje lahko potencira znotrajcelično akumulacijo etidijevega bromida. Kot 
pozitivno referenco smo vključili znan efluksni inhibitor verapamil (Kovač in sod., 2014b). 
 
Rezultati so pokazali znatno povečano akumulacijo etidijevega bromida v prisotnosti 
eteričnega olja semen A. katsumadai. Akumulacija etidijevega bromida je bila celo za 1,7-
krat boljša v prisotnosti 0,5 MIK eteričnega olja, v primerjavi z verapamilom, kot pozitivno 
referenco. Povprečna akumulacija v prisotnosti 0,25 MIK eteričnega olja je bila skoraj 
enaka, kot v prisotnosti 0,5 MIK olja, le čas, potreben za dosego maksimalne akumulacije je 
bil nekoliko daljši. Postopno upadanje akumulacije etidijevega bromida po tem, ko je 
dosegel plato, se je najverjetneje zgodilo zaradi olajšanega vstopa etidijevega bromida 
zaradi vpliva olja na membrano, ali zaradi nezadostne kapacitete olja za blokado efluksa 
(Kovač in sod., 2014b). 
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Zaradi učinkovite odpornostno modulatorne in efluks inhibitorne učinkovitosti eteričnega 
olja semen A. katsumadai smo želeli identificirati tarčno spojino, odgovorno za to aktivnost. 
Analizirali smo kemijsko sestavo eteričnega olja in identificirali 95 % prisotnih spojin. Med 
spojinami, ki so bila zastopane v koncentraciji, višji od 1 %, so bile farnezol, 1-8-cineol, α-
humulen, cimen, α-felandern, 2-butanon, 4-fenil, α-terpineol in β-pinen. Začetni presejalni 
test nas je vodil do podrobnejše analize učinkovitosti spojine α-pinen, ki je bila v olju 
zastopana v koncentraciji 2,2 %. Zaradi boljše aktivnosti v začetnih testih smo nadalnje 
raziskave izvedli z enantiomero (-)-α-pinene. 
 
Minimalna inhibitorna koncentracija (-)-α-pinena je bila 1000 mg/l ali višja pri vseh 
testiranih sevih C. jejuni, vključno s tistimi, vključenimi v teste modulatorne aktivnosti. 
Potrjeni visoki MIK-i kažejo nesignifikantno protimikrobno učinkovitost (-)-α-pinena. Kot 
potencialni modulator odpornosti je bil (-)-α-pinen testiran v koncentracijah 62,5 mg/l in 
125 mg/l v kombinaciji z antibiotikoma ciprofloksacinom in eritromicinom, razkužilom 
triclosan in substratom efluksnih črpalk etidijevim bromidom na referenčnem sevu C. jejuni 
NCTC 11168. V nižji testirani koncentraciji je povečal učinkovitost testiranih 
protimikrobnih sredstev za do dvakrat, v višji koncentraciji pa od 32 do čez 256-krat. 
Podobno močna učinkovitost je bila opažena tudi pri eteričnem olju.  
 
Pred oceno vpliva (-)-α-pinena na akumulacijo etidijevega bromida smo preverili vpliv obeh 
koncentracij spojine na integriteto membrane na referenčnem sevu C. jejuni. S tem smo 
želeli ovreči vpliv na prepustnost membrane kot glavni mehanizem modulatornega 
delovanja (-)-α-pinena. Membranska integriteta kulture, tretirane z 62,5 mg/l je bila po eni 
uri celo za 20 % višja od netretirane kulture, medtem ko je višja koncentracija (125 mg/l) 
znižala membransko integriteto za 39 %. 
 
Obe koncentraciji (-)-α-pinena sta bili testirani za sposobnost povečanja intracelularne 
akumulacije etidijevega bromida v referenčnem sevu C. jejuni. Uporaba nižje koncentracije 
je rezultirala v višji akumulaciji in obenem ni imela negativnega vpliva na membransko 
integriteto, zato smo jo uporabili v testih na večjem številu sevov. To nam je omogočilo 
preučevanje samega efluks inhibitornega učinka. Opazili smo relativno povišanje 
akumulacije etidijevega bromida v prisotnosti (-)-α-pinena pri vseh šestnajstih testiranih 
sevih. (-)-α-pinene je bi sposoben povečanja akumulacije etidijevega bromida znatno bolje 
kot referenčna inhibitorja CCCP in reserpine v  vseh testiranih sevih, kar potrjuje njegovo 
izjemno dobro efluks inhibitorno učinkovitost. Spojina je obdržala enak nivo aktivnosti tudi 
v koncentraciji do 8 mg/l, kar nakazuje na to, da je najverjetneje bil glavna spojina 
eteričnega olja A. katsumadai, ki je inhibirala efluks, vendar tega zaradi nepoznavanja 
enantiomerne sestave α-pinena v eteričnem olju ne moremo potrditi. 
 
Z namenom določitve tarčnega efluksnega sistema spojine (-)-α-pinene, smo akumulacijo 
etidijevega bromida testirali na divjem sevu in mutantah s prekinjenim bralnim okvirom 
efluksnih genov cmeB in Cj1687. Akumulacija etidijevega bromida je bila v mutantah 
znatno nižja v primerjavi z divim sevom, kar nakazuje na odsotnost tarče (-)-α-pinena v 
omenjenih mutantah. Iz teh rezultatov sklepamo, da sta efluksni črpalki CmeABC in Cj1687 
glavni tarči efluks inhibitornega delovanja (-)-α-pinena. 
 
Da bi razvozlali bakterijski adaptacijski odziv na tretiranje s subinhibitorno koncentracijo   
(-)-α-pinena, ki smo jo uporabili v testih akumulacije etidijevega bromida, smo izvedli 
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analizo izražanja genov na nivoju celotnega genoma referenčnega seva C. jejuni. Pri tem 
smo uporabili tehologijo DNA mikromrež in kvantitativnega PCR v realnem času. Po 2-
urnem tretiranju bacterij C. jejuni z 62,5 mg/l (-)-α-pinena, je bilo 129 genov različno 
izražanih, v primerjavi z netretirano kulturo. Pri tem smo upoštevali kot statistično značilne 
spremembe v izražanju samo tiste, ki so presegle dvakratno spremembo. Od teh je bilo 109 
pozitivno raguliranih in 20 negativno reguliranih. Najmočneje pozitivno regulirani (več kot 
10-krat) so bili geni, ki kodirajo šaperone (grpE, dnaK, clpB) in regulator odziva na toplotni 
šok, hrcA. Dodatna dva pozitivo regulirana gena (2 do 4-krat), vključena v odziv na toplotni 
šok, sta bila gena, ki kodirata šaperonine groES in cbpA ter transkripcijski represor hspR. 
Poleg genov, vključenih v odziv na toplotni šok, so bili pozitivno regulirani tudi geni 
efluksnih črpalk cmeABC, in sicer za 2,7 do 2,2-krat. 
 
Spremembe v izražanju genov, ki jih je povzročil (-)-α-pinen, so bile izjemno podobne 
tistim, ki so jih predhodno opazili v mutanti z okvarjenim transkripcijskim regulatorjem 
hspR. To so močno povečano izražanje genov grpE, dnaK, clpB in hrcA. Enostaven model 
odziva na toplotni šok predlaga represijo groES in groEL s strani regulatorja hrcA in 
represijo operona dnaK, cbpA in clpB s strani represorja hspR, ki v primeru toplotnega šoka 
postane de-reprimiran. To posledično povzroči pozitivno regulacijo transkripcijskega 
regulatorja hrcA. Glede na naše rezultate se pri tretiranju C. jejuni z (-)-α-pinenom sproži 
podobna kaskada dogodkov, kar kaže na to, da igra mehanizem odziva na toplotni šok 
pomembno vlogo v bakterijski adaptaciji na ta kemični stres. Podoben odziv so opazili tudi 
v drugi študiji, in sicer po tretiranju C. jejuni z naravnim protimikrobnim sredstvom benzil 
izotiocianatom. 
 
Da bi potrdili vlogo teh genov v adaptacijskem odzivu C. jejuni, smo pripravili mutanti v 
genih hspR in hrcA in jih uporabili v fenotipskih testih. Rast mutant s prekinjenimi bralnimi 
okvirji genov hspR in hrcA ter divjega tipa C. jejuni NCTC 11168 je bila nato testirana v 
prisotnosti in odsotnosti (-)-α-pinena. Divji sev NCTC 11168 je rastel najboljše v danih 
pogojih, nakar je sledil hrcA ter nazadnje hspR. Rast v prisotnosti (-)-α-pinena je bila slabša 
kot v odsotnosti (-)-α-pinena pri vseh treh sevih. Ker je bil trend padajoče rasti opažen v 
obeh mutantah, tako ΔhspR, kot tudi ΔhrcA, sklepamo, da imata oba transkripcijska 
regulatorja pomembno vlogo v adaptacijskem odzivu na tretiranje z (-)-α-pinenom. 
 
Mutanti ΔhspR in ΔhrcA in divji tip C. jejuni NCTC 11168 so bili dodatno fenotipsko 
okarakterizirani s pomočjo fenotipskih mikromrež Biolog. Preverjali smo njihovo 
sposobnost rasti na različnih virih ogljika ter v prisotnosti različnih osmolitov in pH. S tem 
smo želeli pojasniti vlogo okvarjenih genov v adaptaciji na tovrstne strese. Rast mutant smo 
primerjali z rastjo divjega tipa. Mutanta ΔhspR je rastla bolje na nekaterih osmolitih, kot so 
na primer 6 % NaCl s KCl, natrijev sulfat, natrijev format, natrijev laktat in natrijev fosfat, 
medtem ko je bila rast mutante na teh substratih ΔhrcA znatno inhibirana. Še več, mutanta 
ΔhrcA ni bila sposobna izrabljati cele vrste virov ogljika tako učinkovito kot divji tip. 
 
Na podlagi teh rezultatov sklepamo, da igra odziv na toplotni šok pomembno vlogo v 
adaptaciji C. jejuni na različne strese, kot so osmotski stres in kemični stres, vključno s 
stresom tretiranja z efluksnim inhibitorjem (-)-α-pinenom, vendar natančen mehanizem 
odziva še ni popolnoma pojasnjen. Ena izmed ovir na poti k popolnemu razumevanju 
adaptacijskega odziva so tudi kompleksne posttranslacijske regulacije transkripcijskih 
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represorjev HspR in HrcA, ki jih ni mogoče pojasniti z eksperimenti na transkripcijskem 
nivoju. 
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